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INTRODUCTION 
 
 It is always our first priority to select regional anesthesia  in almost all 
procedures as much as possible.  The subarachnoid block (or intra thecal) 
and epidural anaesthesia is a wonderful method of giving anaesthesia in 
lower abdominal and lower limb surgeries. 
 With the help of lignocaine and bupivacaine we are using spinal 
blockade for long time since its invention. 
 Lignocaine and Bupivacaine are the drugs used for long time.  In this 
setting one of the newer drug Ropivacaine has emerged and which is 
available as only isobaric solution.  It is used  mainly for epidural, nerve 
plexus blocks.  Now only it is available as 0.75% solution and most of  us 
are not using it very much for subarachnoid block.  That’s why Ropivacaine 
was chosen as 0.75% intra thecal for my study.  Dexmedetomidine is one of 
the newer drug very much used for sedation and to potentiate the effect of  
local anaesthetics.   
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AIM OF STUDY 
  
To compare the clinical effects of intra thecal ropivacaine and 
ropivacaine with dexmedetomidine  with respect to  
1. Onset of sensory and motor blockade 
2. Hemodynamic stability 
3. Duration of sensory and motor blockade 
4. Associated complications 
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HISTORY OF SPINAL ANAESTHESIA  
 First spinal anesthesia by J.Leonard corning 1855 – 1923, New york 
Neurologist in 1885.   He accidentally pierced the dura while experimenting 
with cocaine on the spinal nerves of a dog.  Later he deliberately repeated the 
intradural injection, called it spinal anesthesia and suggested it might be used 
in surgery. 
 Lumbar puncture standardized as a simple clinical procedure by 
Heinrich Irchacus Quinke (1842 -1922) of Kiel in Germany in 1891 and by 
Essex wynter (1860 – 1945) in England in the same year. 
 First planned spinal analgesia for surgery in man performed by August 
Bier (1861 – 1949) in August 1898 in Kiel when he injected 3ml of 0.5% 
cocaine solution into the 34 year old labourer.  After using it on 6 patients he 
and his assistants each injected cocaine into others theca. 
 Adrenaline was used to increase duration to  reduce toxicity of spinal 
analgesia in 1903. 
 Spinal analgesia was little used until Gaston Labats work in 1921.  He 
used procaine crystals dissolved in cerebro spinal fluid together with 
barbotage and trendelenburg position.  Meister discovered the analgesia 
properties of nubercaine in 1929 and it was used as hyperbaric solution by 
keyes and Mc Lelland of New york at 1980. 
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 Howard Jones of London published his technique using hypobaric 
solution in 1930. 
 First amide local anesthetic lidocaine was synthesized by lofgren in 
1943. 
 Bupivacaine was first used for intradural block in 1966. 
 In recent years there has been a steady increase in the popularity of 
spinal block for surgery. 
 In 1979, Albright published an alarming editorial which associated 
with long acting local anesthetics bupivacaine and etidocaine with cardiac 
arrest following regional anesthesia.  Albright reported 6 cases of presumed 
accidental intra vascular injection of either bupivacaine or etidocaine which 
caused sudden ventricular arrhythmias occurring at the same time as severe 
convulsions. 
 Subsequently sporadic cases of maternal death resulting from 
accidental iv injection of 0.75% bupivacaine at the time of extradural 
injection for caesarian section were reported.  In the UK 5 deaths were 
reported after i.v regional anesthesia.  This sequence of events provided the 
impetus to develop a new local anesthetic drug. 
 Ropivacaine was introduced in clinical practice  in 1996 and has 
consistently demonstrated an improved safety profiles over bupivacaine with 
a reduced CNS and  cardio toxic profile. 
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 Ropivacaine was approved for a new route of administration, intra 
thecal route in the European Union in Feb 2004. 
 In 1948 Raymond P.Ahlquist proposed the designation α and β 
adrenergic receptors and various subtypes of these two main classes have 
been characterized since then.  Esmolol was introduced in 1985 as a short 
acting β 2 Antagonist that  effectively control the heart rate during anesthesia.  
Labetalol a unique agent introduced in 1976 antagonises  
α and β receptors.  
 The α 2 adrenergic agonists provide sedation, anxiolysis, hypnosis 
analgesia and sympatholysis.  The initial impetus for the use of  α 2 agonist in 
anaesthesia resulted from observation made in patients during anaesthesia 
who were receiving clonidine therapy.  This was soon followed by a 
description of the MAC reduction of halothane by clonidine. 
 Dexmedetomidine is a more selective α 2 agonist with a 1600 greater 
selectivity for the α 2 receptor compared with α 1 receptor.  It was introduced 
in clinical practice in the united states in 1999 and approved by the FDA 
only as a short term sedative for mechanically ventilated  adult ICU patients. 
 Dexmedetomidine is now being used off label outside of the ICU in 
various settings including sedation and adjunct analgesia in the operating 
room, sedation in diagnostic  procedures units and for other applications 
such as withdrawal detoxification amelioration in  adult and paediatric 
patients. 
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 To conduct a study on spinal  anesthesia we must have through 
knowledge about the vertebral column, spinal cord anatomy and dermatomal 
distribution of nerves and physiology  of the nerve function and detailed 
pharmacology, about the drugs which we use is obsolutely necessary to 
understand everything.   Except strangulated inguinal hernia almost all 
inguinal hernias are done under regional subarachnoid block.   
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VERTEBRAL COLUMN 
 The bones of the vertebral canal are landmarks, identified both by the 
palpating fingers and the exploring needle by which the anesthetist performs 
spinal and epidural blocks.  As well as being able to recognize these, 
landmarks, it is essential to be familiar with the feel of the inter vertebral 
ligaments as they yield  to the advancing needle and to have intimate 
knowledge about the relationship of nervous tissue and dural sheath to the 
bony structures. 
 The vertebral column consists of 7 cervical, 12 thoracic, 5 lumbar, 5 
sacral and 4 or 5 coccygeal vertebrae.  The sacral and coccygeal vertebrae 
are fused in adult life. 
 The column has 4 curves of which thoracic and sacral are primary and 
are concave anteriorly therefore when the spine is fully flexed the cervical 
and lumbar curves are obliterated.  In the supine position the 3rd lumbar 
vertebra marks the highest point of lumbar curve whereas the 5th thoracic is 
the lowest point of the dorsal curve.  Kyphosis, lordosis, scoliosis and  
arthritis of the spine may upset the curve and make lumbar puncture 
difficult. 
 The direction of the spinous process determines the direction in which 
the spinal needle must be inserted.  The spinous processes of the cervical, the 
first two thoracic and  the last four lumbar vertebra are all practically 
horizontal and are therefore opposite the bodies of their respective vertebra.  
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The other spinous processes are inclined downwards  and their tips being 
opposite the bodies of the vertebra next below; exception, tip of the first 
lumbar is opposite the inter vertebral disc.  The 5th lumbar spine overhangs 
the lumbosacral inter space. 
Some useful surface markings: 
 The vertebra prominens (spine of C7) is easily palpable.  The tip of the 
spine of T7 is opposite the inferior angle of the scapula with the arms at the 
sides of the body. 
 The highest points of the iliac crests are usually on a line crossing the 
spine of L4 or the L3 L4 inter space.  The tips of the spine of T7 is opposite 
the inferior angle of the scapula with the arms to the sides. 
 The  dimples over the posterior superior iliac spines are on a line 
crossing the second, posterior sacral foramina and at this level the dural sac 
in the adult usually ends.  The lower end of the spinal cord terminates at the 
level of the upper border of the body of L2. 
 
 
 
 
 
 
 
17 
 
THE VERTEBRAL CANAL 
 Bounded in front by the bodies of the vertebrae and inter vertebral 
discs, posteriorly by the laminae, ligamenta flava and the arch, which bears 
spinous processes and by ligaments between them called interspinous; 
laterally by the pedicles and laminae.  Size and shape vary but is larger in 
cervical and lumbar regions. 
Contents 
1. Roots of spinal nerves 
2. Spinal membranes with their enclosed cord and cerebrospinal fluid. 
3. Structures : Vessels 
Fat 
Areolar tissue of extra dural space  
The narrowest part is between T4 and T9.  The stenosis of the vertebral canal 
may cause cord compression after central neural blockade.  This may be 
intensified should there be extradural haemorrhage. 
The spinal meninges: 
 Has 3 coverings 
1. The dura mater 
2. Arachnoid mater 
3. Pia mater 
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The dura mater: 
 The dural coverings of the brain is a double membrane between the 
walls of which lie cerebral venous sinuses.  The dura mater that encloses the 
cord consists of a continuation of the inner layer of the cerebral dura which 
is made up of dense fibrous tissue, the outer layer of cerebral dura terminates 
at foramen magnum where it merges with the periosteum enclosing the skull 
and is therefore represented by the periosteal lining of the vertebral canal.  
 The dural sac extends to the level of the 2nd segment of sacrum.  
Occationally if ends as high as L5 at other time if extends to S3.  As a result 
of this it occationally possible to perform an inadvertant spinal tap 
(injection) during that course of a caudal injection.  The dural sheath then 
continuous as the covering of the filum terminale to end by adhering to the 
periosteum on the back of the coccyx.  The sac widens out in both cervical 
and lumbar regions corresponding to the cervical and lumbar enlargements 
of the cord.  It lies rather loosely within the spinal canal buffered in the 
epidural fat, but it is attached at the following points to its bony 
surroundings. 
a) Above to the edges of the foramen magnum and to the posterior aspect 
of the bodies of 2nd and 3rd cervical vertebrae. 
b) Anteriorly, by the slender filaments of the fibrous tissue to the 
posterior longitudinal ligament. 
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c) Laterally, by prolongations along the dorsal and ventral root of nerves 
which fuse into the common sheath and which then blend with the 
epineurium  of the resultant  spinal nerves. 
d) Inferiorly, by the terminale to the coccyx.  However, the dural sac is 
completely free posteriorly. 
The arachnoid mater: 
 This is a delicate mambrane which lines the dural sheath and which 
sends prolongations along each nerve roots. Above it is continuous with the 
cerebral arachnoid, which loosely invests brain and which dips into the 
longitudinal fissure between the cerebral hemispheres. 
The pia mater: 
 It is the innermost one and it is a vascular connective tissue membrane 
that closely invests the brain and spinal cord and projects into their sulci and 
fissures.  It is thickened anteriorly into the linea splendens along the length 
of the anterior median fissure.  On either side it forms the ligamentum 
denticulatum, and series of triangular fibrous strands attached at their apices 
to the dural sheath.  They are 21 in number and lie between the spinal nerves 
down to the gap between the 12th thoracic and 1st lumbar root.  The 
lowermost denticulatum is bifid and is crossed by the 1st lumbar nerve root.  
Inferiorly,  the pia is continued downwards as the filum terminale, which 
pierces the lower head of the dural sac and then continuous to the coccyx 
with a covering sheath of dura. 
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The spaces related to the spinal meninges: 
These are the 
 Sub arachnoid space 
 Subdural space 
 Epidural space 
THE SUBARACHNOID (INTRA THECAL) SPACE contains the CSF.  It 
is traversed by incomplete trabaculae, the posterior subarachnoid septum and 
the ligamentum denticulatum. 
 This space communicates with the tissue spaces around the vessels in 
the pia mater that accompany them as they penetrate into the cord.  These 
continuations of the subarachnoid space have been described as breaking up 
into fine ramifications that surround individual nerve cells (the Virchow 
Robin spaces) and which have been considered as pathways by which a 
spinal anesthetic permeates the cord.   It is debatable whether such spaces 
actually exist; they are probably artifact produced by syrinkage of the course 
of fixation of the historical material. 
 SUBDURAL SPACE is a potential space between dura and pia-
arachnoid into which a catheter or local analgesic solution may track.  It has  
no communications with the subarachnoid space. 
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EPIDURAL OR PERIDURAL SPACE: 
 Spinal dura mater represents meningeal layer of the dura mater of the 
brain.  Epidural space is situated between the spinal dura and vertebral canal. 
Average diameter 0.5cm and widest in midline posteriorly in the lumbar 
region. 
Boundaries are 
• Foramen magnum superiorly 
• Sacrococcygeal membrane inferiorly 
• Lamina and ligaments posteriorly 
• Posterior longitudinal ligament anteriorly 
• Pedicles and inter vertebral foramina laterally 
Contants: 
 Dural sac 
 Spinal nerve roots 
 Extradural plexus of veins 
 Spinal arteries 
 Lymphatics and fat 
The plexus of veins have no valves and constitute the valveless vertebral 
plexus of BATSON.  They connect pelvic veins below with the intra cranial 
veins above.  They become distended with increased in intra abdominal 
pressure with IVC obstruction. 
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 There are 58 inter vertebral foramen and their patency is important 
factor in controlling the height of analgesia.  The shape of the space is 
triangular and a dorso median fold of membrane  occationally divides the 
space into compartments which don’t always communicate freely with each 
other.  Such abnormalities may explain patchy analgesia. 
 The dura mater is attached to the margins of the foramen magnum.  
But this doesn’t  prevent the passage of analgesic drug to the cranial  cavity.  
It ends at the lower border of the second lumbar vertebrae.  Distance 
between the skin and extradural  space is 4 – 5 cm.  There is a negative 
pressure in the extradural space in only about 80% of patients. 
The vertebral ligament bounding the canal 
1. Supra spinous ligament between the tips of spinous processes C7 to 
sacrum.  
2. Inter spinous ligament joining the spinous process together. 
3. Ligamenta flava 
Running from lamina to lamina composed of  yellow elastic  
fibres and it is thicker from above downwards. 
4. Posterior longitudinal ligament 
On the posterior surface of vertebral body. 
5. Anterior longitudinal ligament 
On the anterior surface of the vertebral body 
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Midline spinal puncture pierces the first three ligaments.  In lateral  approach 
only ligamenta flava are encountered. 
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THE SPINAL CORD 
 It is an elongated part of the nervous system which occupies upper 2/3 
of the vertebral canal and is 45cm long.  Extend from upper border of the 
atlas to the upper border of the 2nd lumbar vertebra and lower still in infarcts.  
It continuous as medulla oblongata upwards and ends in conus medullaris.  
The nerve toots which pass out transversely in early life become more 
oblique in direction in adults.  They are  bathed in CSF and will be affected 
by local analgesic solution injected in the lumbar area.  Spinal cord is 
ensheathed by three membranes. 
SPINAL SEGMENTS: 
 The cord is divided into segments by the pairs of spinal nerves, which 
arise from it.  These pairs are 31 in number. 
a) 8 Cervical 
b) 12 thoracic 
c) 5 lumbar 
d) 5 sacral 
e) 1 coccygeal 
The nerve roots within the dura have no epineural sheaths and are easily 
affected by local analgesics.  The cord is not transversely blocked by 
spinal analgesia. 
Spinal nerves: 
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 Anterior root is efferent and motor.  Posterior root is larger than 
anterior and is largely sensory.  Posterior root has a ganglion and conveys 
fibres of all sensation with automatic fibres. 
Pain pathway in the spinal cord: 
 Pain and temperative fibres enter the posterior horn where they end 
around cells in the grey matter.  Fibres then cross to cortra lateral side 
within three segments and ascend in the lateral spino thoracic tract to the 
thalamus.  Tactile impulses ascend in the ventral spinothalamic tract to 
the thalamus.  Deep or muscle sensory impulses ascend in the  posterior 
columns and spinocerebellar tracts.  Vibration impulses ascend in the 
posterior columns. 
 Anterior and posterior nerve roots within its sheath unite in the 
intervertebral foramen to form the main trunk which soon divide into 
anterior and posterior divisions. 
 Local analgesic drugs injected into the sub arachnoid space can soak 
along the nerve trunk for as much as 2cm beyond the inter vertebral 
foramen.  Analgesic drugs affect autonomic, sensory and motor fibres in 
that order and  fibres which block easily hold the drug longest and thus 
sensory block lasts longer than motor and usually ascends two segments 
higher up the cord than motor block. 
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Segmental levels: 
  Perineum  - S1 – S4 
  Inguinal region - L1 
  Umbilicus  - T10 
  Sub costal arch - T6 – T8 
  Nipple line  - T4 – T5 
  Second inter costal space – T2 
  Clavicle  - C3 – C4 
Segmental levels of spinal reflexes: 
 Epigastric  - T7 T8 
 Abdominal - T9 - T12 
 Cremastric - L1 L2 
 Plantar - S1 S2  
Blood supply of spinal cord: 
 It is supplied by 2 posterior spinal arteries which arise from posterior 
inferior  cerebellar arteries and , anterior spinal artery which is formed by the 
branch of vertebral artery of each side. 
 Anterior spinal artery is reinforced by many  anterior by which artery 
of ADAMKIEWICZ artery radicularis magna is very important which can 
enter anywhere between T5-L2 and usually (75%) it enters from left side.  
Damage to this artery by needle can lead to cord ischemia and paraplegia. 
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CEREBRO SPINAL FLUID 
Source:  From the choroid plexuses of the third, fourth and lateral ventricles 
by either secretion or dialysis. 
Circulation: Otherwise called the third circulation.  It forms a short circuit 
between the arterial and venous circulation.  Fluids after formation enters 
into the lateral ventricles, passes through  on each side, the foramen of 
MANRO to the third ventricle and then through the agueduct of SYLVIUS 
to fourth ventricle.  Then fluid enters into the subarachnoid space through 
the central foramen of MAGENDIE and the lateral foramina of LUSCHKA  
and reaches cisterna magna.  It baths whole of CNS and is absorbed into 
venous sinuses through the arachnoid villi. 
 Ordinary dose of analgesic drugs injected into the spinal subarachnoid 
space don’t reach the fourth ventricle. 
Physical characteristics: 
 Clear, colourless, slight opalescence due to globulin spe.gr.at 370c is 
1003 – 1009. 
 The density is more dependent on the temperature and on the 
contained sodium, chloride and Co2.   Increased  in  DM, uremia and old age.  
5 – 6 lymphocytes will be present and increase of cells indicates meningeal 
irritation.  Quandity 110 – 150ml half of which is present in the cranium and 
half in the spinal canal. 
 
28 
 
Pressure:  100 – 200mm of H2O in lateral position. 
  300 – 400mm of H2O in vertical position. 
Factors which increase the pressure are sleep, neoplasm, ↑ Co2 tension, CCF 
and mediastinal tumours, straining and couging.  Decreased in dehydration 
and with barbiturates.  About 500 ml is secreted per day. 
Chemical characteristics: 
 Alkaline 
 pH 7.6 
 Protein 24 – 40mg % 
 Sugar 45 – 80 mg percent 
 Sodium chloride 750 mg % 
 Urea 10 – 30 mg % 
 Bicorbonate 24 mg 1 litre 
No antibodies present in the CSF and there is always chance for infection.  
Contains small amount of cholinesterase.  After spinal anaesthesia albumin 
and globulin will increase and sugar decreases and magnesium increases 
than in blood. 
Functions: 
1. It is a fluid cushion to protect brain and spinal cord. 
2. Regulates the volume of the cranial content. 
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3. It has a slight function in the metabolic exchanges of nervous tissue 
and may take the place of lymph.  CSF amount is decreased in 
dehydration and after lumbar puncture. 
Advantages of SAB over general anaesthesia: 
• Cheaper 
• Less risk of pulmonary aspiration 
• Distribution of blood chemistry is minimal 
• Less bleeding 
• Decreased incidence of thrombo embolism 
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SYSTEMIC EFFECTS OF SPINAL ANAESTHESIA 
Cardiovascular system: 
 Hypotention (1) due to venodilatation, by the symphathetic block (2) 
dilatation of postarteriolar  capillaries (3) decreased cardiac output. 
Decreased cardiac output due o decreased venous return, brady cardia. 
Bradycardia due to 
- decreased atrial pressure because of decreased veinous return 
(bainbridge reflex) 
- Direct inhibition of cardio accelerator fibres (T1 to T4) 
4. Paralysis of nerve supply to adrenal glands with consequently 
decreased catecholamine release. 
5. Direct absorbtion of drug into the systemic circulation. 
6. Compression of inferior vena cava & aorta by pregnant uterus, 
abdominal tumours (supine hypotension syndrome. 
Nervous system: 
 Order of blocking nerve fibres. 
- Autonomic preganglionic – β  fibres 
- Temperature fibres – cold before warm 
- Pain-prick fibres 
- Fibres conveying pain greater than pin prick 
- Touch fibres 
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- Deep pressure fibres 
- Somatic motor fibres 
- Fibres conveying vibratory sense and proprioceptive impulses. 
During recovery return of sensibility in the reverse order was assumed, but it 
has been suggested that symphathetic activity returns before sensation.  The 
patient may complain of pain due to tourniquet and increased concentration 
of analgesic will avoid this.  LA drugs mainly acts on here roots.  Drug 
molecules removed from intradural space by absorbtion into the blood 
vessels.  In intradural block, symphathetic fibres are blocked two to three 
segments higher than sensory fibres.  The difference between sensory and 
motor block is slight. 
Respiratory system: 
 Tidal volume, minute volume, arterial oxygen tension are well 
maintained in normal individuals but in patient of COPD whose expiration is 
dependent on abdominal muscles and can’t  bear loss of lower intercostals. 
There can be severe impairment of respiratory function if block is high 
enough to block abdominal and lower intercostals muscles. 
 Apnoea seen during spinal anaesthesia is usually due to severe 
hypotension causing medullary ischemia.  Other causes of apnoea are  
a) High spinal – block phrenic nerve 
b) Total spinal – due to accidental intrathecal injection of large volume 
of drug during epidural. 
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c) Intra vascular injection and systemic toxicity. 
Gastro intestinal system: 
 Symphathetic block and parasympathetic overactivity produces 
contracted bowel and relaxed sphincters.  Peristalsis is increased.  Nausea 
and vomiting due to hypotension, bile in stomach due to relaxed pyloric 
sphincter, handling of abdominal structures and psychological. 
Genito urinary system: 
 Paralysed and engorged penis is one of the signs of successful block.  
Urinary retention is a very common post operative problem due to blocking 
of S234 fibres.  Renal functions are not impaired unless mean arterial 
pressure falls below the critical pressure of kidney for autoregulation (which 
is 55mm of Hg).   
Liver: 
 Hypotension can decrease liver blood flow but impairment is minimal. 
Endocrine system: 
• Stress response to surgery is inhibited. 
• The response to insulin is augmented and there can be hypoglycemia. 
• Usual increase in ADH during surgery is suppressed. 
Thermoregulation: 
 Vasodilatation causes heat loss which is compensated by 
vasoconstriction  above the  block by shivering. 
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Local anaesthetics: 
Classified into  
Aminoesters and Aminoamides 
Aminoesters causes high incidence of allergic reactions. 
Aminoamides: 
 (e.g) lignocaine, bupivacaine, ropivacaine 
• Metabolished primarily in the liver 
• It has low incidence of allergic reactions 
• Solutions are stable (not destroyed even by autoclaving) 
Mechanism of action of LA: 
 Drug in non-ionized form penetrates the axonal membrance and inside 
it gets dissociated.  This ionized form binds to receptor situated in sodium 
channel in inactivated state from inner side, blocking the channel and thus 
preventing depolarisation and hence action potential.  LA enters at node of 
Ranvier. 
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SPINAL ANESTHESIA: (INTRATHECAL BLOCK) 
 It is otherwise called as sub arachnoid block and is one of the most  
commonly used technique. 
 One of the most important piece of equipment in the hand of the 
anaesthetist practicing regional  anaesthesia is NEEDLE. 
 Following initial development of hypodermic needles by Francis 
Rynd of Dublin and others proved that regional anaesthesia of the 
extremities possible.  Sep 15th 1884 is hailed as the birthdate  of regional 
anaesthesia when Carlkoller demonstrated the anaesthetic properties of 
cocaine applied to the conjunctiva. While Koller’s interest revolved around 
ophthalmic procedures, William Halsted experimented and proved that 
regional anaesthesia of the limbs  was possible by means of injections into 
the brachial plexus and posterior tibial nerve.  Corning is credited with the 
first needle designed for spinal anaesthesia.  The needle was 3 ½ - 4 inches 
long and was made up of gold or platinum along with an introducer ½ inch 
in length.  August Bier advocated large bore needles on the ground that these 
didn’t require an introducer.  However he was criticized on the ground that 
wide bore needles caused unnecessary trauma and pain to the patient. 
Needles for spinal anaesthesia: 
1. Quincke bevel spinal needles 
Various needle were described from time to time but none of these  
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stood the test of time till Quincke needle was introduced into practice.  This 
needle is popular even to this day which have a lower incidence of post dural 
puncture headache (PDPH).  Quincke needle has a slanting bevel and a 
stillette, which is flush with the tip of the needle.  This makes the entry of the 
needle very smooth and less painful. 
2. Pencil point spinal needles: 
Hast and Whitcre in 1951 introduced a solid end needle tapered to  
pencil point with an orifice on the side of the needle just proximal to the tip.  
This has non cutting bevels and spreads the dural fibres rather than cutting 
through them thereby minimizing the incidence of PDPH.  The pencil point 
needles are the Whitcre needle or sprotte type difference between them being 
very slight.  Whitcre needle has a conical tip with a rectangular side opening 
and with sharp edges.  The Sprotte needle has a tapering end which is most 
blunt than the Whitcre needle tip.  It has an oval lateral opening with smooth 
edge proximal to the tip.  The side hole on the Whitcre needle is close 
enough to the needle tip to ensure an accurate delivery of the local anaethetic 
drug into the subarachnoid space.  These pencil point needles are finebore 
needles require and introducer needle for insertion.  The pencil point needles 
are gaining popularity although their use in India where economic 
considerations play and important role. 
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3. Double hole pencil point needle (Eldor spinal needle) 
There will be faster flash back of CSF on dural puncture and the immediate 
dispersion of the injection is possible. 
4. Tip holed spinal needle: 
Also called ball pen needle.  There have been very few users of this  
Needle, primarily because of the concern of tissue coring by the sharp edge 
of the needle. 
 There are dura cutting and dura separating needles. 
Dura cutting: 
 Standard Quincke-Babcock needle comes in this group.  The incidence 
of post dural puncture headache is high with these needle.  But the needle is 
cheaper one. 
Dura splitting: 
 These are pencil-tipped needles.  (Whitcre, sprotte needles are the 
continuously available types, PDPH is less with this needle the problem is 
costly one. 
 Before going to the  procedure for subarachnoid block it is essential to 
know about the drugs which we use . 
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PHARMACOLOGY OF LOCAL ANAESTHETIC DRUGS 
 Modern local analgesia began with the introduction of cocaine into 
medical practice in 1884.  First used by CARLKOLLER for anaesthetizing 
cornea. 
 Local anaesthetics are classified on the  basis of chemical structure 
and on the duration of action. 
Based on chemical structure: 
 Chemically local anaesthetics are consist of a benzene ring separated 
from the tertiary amide either by ester (or) amide linkage.  Based on this 
intermediate chain these are classified as aminoesters and aminoamides. 
 Aminoesters: 
 (e.g) procaine, chlorprocaine, tetracaine, benzocaine, cocaine 
Features:  
• Esters are metabolized by pseudocholinestrase except cocaine which is 
metabolized by liver. 
• More incidence of allergic reactions. 
• Solutions are unstable. 
 Aminoamides 
(e.g) lignocaine, mepivacaine,  
Prilocaine, Bupivacaine 
Etidocaine, Ropivacaine 
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Amides are metabolized mainly in the liver.  Lower incidence of allergic 
reactions is the main advantage.  The solutions are stable one and they are 
not destroyed even by autoclaving. 
Based on duration of action and potency 
 Potency 
• Short duration, low potency 
Chloroprocaine 
Procaine 
• Inter mediate duration and potency 
Lignocaine  
Mepivacaine 
Prolocaine and cocaine 
• Long duration and high potency 
Bupivacine, Dibucaine, Ropivacaine 
Among all chloroprocaine has shortest and dibucaine has the longest 
duration of action. 
Commonly used drugs are lignocaine, bupivacaine, and ropivacaine. 
STRUCTURE OF LA 
LA drugs are water soluble salts of lipid soluble alkaloids and  
composed of aromatic ring and hydrophilic amide with a intermediate chain.  
There are 2 types of inter mediate chain ester and amide and depend upon 
that drugs are classified.  Some change in chemical structure result in 
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pharmacological effect (eg) piperadine ring instead of tertiary amine we get 
mepivacaine result in increase in lipid solubility and duration of action.  The 
addition of propyl or butyl group to the amine end of mapivacaine results in 
ropivacaine (or) bupivacaine respectively. 
 Bupivacaine exists in two forms called enantiomers which are mirror 
images of molecular structure  (Levo, Dextro).  Each has different 
pharmacodynamical and pharmocokinetic properties and potency and side 
effects. 
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NERVE ANATOMY AND FUNCTIONS 
 Nerves are conducting the signals from the CNS to peripheral nerve.  
Nerves consists of cell body, axon and presynaptic terminal.  The spaces 
between the presynaptic terminal and the cell body of another nerve is called 
synaptic cleft, across which pass neurotransmitters norepinephrine (or) 
acetyl choline. 
 Nerve fibres classified into A & B & C depend upon their myelination 
and diameter and each has its own separate function.  Small diameter axons 
are more susceptible to block than large diameter fibres, however myelinated 
fibres are more sensitive than non-myelinated.  LA drugs by blocking the 
fibre at the node of Ranvier. 
 Resting membrane electrical potential of nerve fibres is -70 mV.  
Impulse generation by entry of sodium inside and potassium outside and 
repolarisation due to reversal of ion movement. 
Site of action at molecular level 
 The nerve membrane is made up of a phospholipid bilayer.  The 
globular proteins like sodium and potassium channels are situated in the 
membrane and is protruding through the lipid bilayer. 
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 Table. Nerve fiber types in mammalian nerve.a 
  
Fiber Type Function Fiber 
Diameter 
(µm) 
Conduction 
Velocity 
(m/s) 
Spike 
Duration 
(ms)  
Absolute 
Refractory 
Period 
(ms) 
A 
 
     
α Proprioception; 
somatic motor 
12-20 70-120   
β 
 
Touch, pressure 5-12 30-70 0.4-0.5 0.4-1 
γ Motor to muscle 
spindles 
3-6 15-30   
δ 
 
Pain, cold, touch 2-5 12-30   
B Preganglionic 
autonomic 
<3 3-15 1.2 1.2 
C 
 
     
Dorsal 
root 
Pain, temperature, 
some mechano-
reception 
0.4 – 1.2 0.5-2 2 2 
Sympa 
thetic 
Postganglionic 
sympathetic 
0.3-1.3 0.7-2.3 2 2 
 
  
Sodium channels 
 10 different types of Na+ channels are identified.  Binding of local 
anaesthetic at sites of voltage gated Na+ channel prevents opening of 
channels and inhibits channel activation.  LA drugs bind to channel pore and 
occlude the pathway. 
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 Na+ channel is bell shaped protein with four domains arranged around 
the central pore. Each domain consists of 6 α subunits (S1-S6).  The short 
loops between S5 & S6 form the pore. 
Potassium channels are tetramers with each of the four subunits forming part 
of the pore through which K+ channels pass. 
Action of LA drugs 
 LA drugs inhibit the peripheral nerve conduction by blocking Na+ and 
K+ channels.  Binding of LA drugs more with open (or) inactivated channels 
than resting state or that dissociate slowly will cause more potent block.  (eg) 
Bupivacaine.  That will cause delay in recovery of cardiac Na+ channels, 
prolong conduction and generate re-entry arrhythmias.  Heart is more 
susceptible to more channel blockade by LA drug than peripheral nerves. 
 Cm- is the minimum concentration of local anaesthetic that will block 
nerve impulse conduction.  Each anaesthetic has its own Cm. 
 Recent evidence says that LA drugs act on 
- G.coupled receptor proteins. 
- Muscarinic receptors. 
- Endothelial nitric oxide. 
Clinical pharmacology: 
Potency: 
 Hydrophobicity is the deciding factor of intrinsic anaesthetic potency. 
 
43 
 
Onset of action: 
 Depends on number of factors like  
(1) Dose and concentration 
(eg) 0.25% Bupivacaine has show onset and 0.5% has  
accelerated onset of action. 
(2) pKa 
It is the pH at which LA drug is 50% ionized and 50% non  
ionized.  Diffusion across the nerve fibre membrane decided by non – 
ionized fraction of the drug.  The higher the pKa,  the greater the ionized 
fraction in solution.  LA drugs which has low value have a fast onset of 
action.  Lignocaine has fast action (pKa 7.6) than bupivacaine (pKa 8.1). 
 This is the rationale of adding sodabicorbonate to local anaesthetic 
which increases pH and so more drug available in non ionized form. 
(3) Type of nerve fibre: 
Smaller axons, myelinated fibres are more sensitive to LA.   
So type B fibres are more easily blocked than type C fibres.  So sequence of 
block is B → C → A and in functional terms it is autonomic → sensory → 
motor and the sequence of recovery is motor → sensory → autonomic.  
Among sensory fibres sequence of blockade is temperature → pain → touch 
→ deep pressure → proprioceptain. 
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Frequency of nerve stimulation 
 A stimulated nerve will be blocked early. 
Duration of action: 
It depends on 
1. Dose 
Increased dose increases duration.  
2. Pharmocokinetic profile of drug 
It includes 
(i) Plasma protein binding 
Agents with high protein binding like bupivacaine has  
prolonged action. In the plasma amide LA drugs bind with α-acid 
glycoprotein, a high affinity limited-capacity protein and albumin, a low 
affinity large-capacity protein.  Low protein will cause low protein bound 
fraction and increases the free fraction and increases the likelihood of toxic 
reactions.  In critically ill patient hypoxia, hypercarbia, acidaemia increases 
free fraction and potentiate toxic effects. 
(ii) Metabolism: 
Esters are metabolized by pseudocholesterase and  
amides metabolized in liver by microsomal enzymes.  Esters have short 
duration of action. 
3.  Addition of vasoconstrictors 
Vaso constrictors decrease the systemic absorbtion of local  
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anaesthetics in blood, so increases the concentration thereby increasing 
duration of action.  Drugs used are 
(a) Adrenaline 
(b) Noradrenaline 
(c) Felypressin 
Intrinsic vasodilatory activity of lignocaine has influence on potency and 
duration of action.  Bupivacaine and other newer drugs has biphasic 
vasoactive response.  At low concentration will cause vacosonstriction and 
high concentration will cause vasodilatation.  The cause for the LA drugs 
producing vasodilatation is nitric oxide release.  Vasoconstrictors are should 
not be used for 
- Ring block of fingers, toes, penis 
- When inhalational agent halothane is used which sensitizes the heart 
to adrenaline. 
- Myocardial ischiemic patients. 
- Hyperthyroid patients. 
- Severe hypertensives. 
- IVRA (Biers block) 
(4) Sodium bicarbonate: 
Addition of sodium bicarbonate (1 ml of 8.4% solution to  
10ml of lignocaine increases both onset and duration of action.  Sodium 
bicarbonate increases the onset by making pH more alkaline so more drug is 
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available in unionized form.  Later carbondioxide released from sodium 
bicarbonate metabolism enters intracellularly making the pH more acidic and 
making more drug to be available in ionized form thereby increasing the 
duration also. 
So addition of sodium bicarbonate 
- Enhances the onset of action 
- Increases the duration of action 
- Improves the quality of the block 
- Decreases the pain of injection 
Pharmacokinetics 
Absorbtion: It depends on 
• Site of injection.  It is proportionate to the vascularity of the site of 
injection.  Systemic absorbtion is highest after inter costal nerve 
block. 
• Addition of vasoconstrictors.  This is the most important factor.  
Addition of the vasoconstrictors increasing the margin of safety by 
decreasing the systemic absorbtion that is why maximum dose of 
xylocaine (lignocaine) with adrenaline is 7mg/kg while without 
adrenaline is 3mg/kg. 
Distribution: 
 Tissue distribution is in proportion to the tissue : blood partition 
coefficient of the LA drug and the mass and perfusion of the tissue.  The 
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plasma concentration of local anaesthetic is decided by distribution and 
clearance of the drug.  Amide group of drugs are widely distributed in tissues 
than ester local anaethetics following systemic absorbtion. 
Metabolism: 
 The ester group drugs are hydrolysed by pseudocholiesterase into the 
metabolite PABA which is a causative factor for the allergic reactions.  
Plasma half life is prolonged in atypical pseudo cholesterase.  Amide group 
drugs metabolished in the liver by hydroxylation and dealkylation and 
willn’t cause the PABA so less likely to get allergic reactions.  Metabolized 
by cytochrome p450 and the enzyme activity depend upon the liver blood 
flow and usage of enzyme inhibitors. 
Elimination: 
 Elimination half life mainly depends upon hepatic metabolism because 
renal excretion of unchanged drug is very minimal.  In heart failure, 
distribution and clearance of the local anaesthetics are reduced. 
Systemic effects and toxicity: 
 Toxicity is proportional to potency. 
Cardio vascular system: 
• Except cocaine all LA drugs are vasodilators in clinically used 
concentrations. 
• Have negative inotropic action on the myocardium. 
48 
 
• These agents depress conducting system.  It is manifested as 
initial tachycardia, hypertension followed by myocardial 
depression, bradycardia, hypotension, ventricular arrhythmias 
and cardiac arrest. 
• Accidental invascular injection of high dosage of LA drugs 
causing blockade of Na+, K+, Ca+, channels in the conduction 
systems in the CNS  and CVS and causes acute collapse. 
Treatment: 
 Lower head 
 100% oxygen 
 Intubation, ventilation 
 Intra venous fluids 
 Epinephrine 
 Cardiac massage 
Cardiotoxicity of bupivacaine is much higher than that of lignocaine.  Recent 
studies tell that ropivacaine, levo-bupivacaine are less likely to dwell on Na+, 
K+ channels and are less likely to impair myocardial electrical conduction 
and contractility.  In animal studies they show increased threshold for 
convulsion and arrhythmias and resusitation after cardiovascular collapse is 
better with ropivacaine and levobupivacaine than bupivacaine. 
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CNS toxicity: 
 Typical sequence is initial excitation followed by depression of 
cerebral tissue (inhibitory neurons are more sensitive than excitatory 
neurons)  
signs and symptoms are 
- Circumoral numbness 
- Dizziness, tongue parasthesia 
- Visual and auditory disturbances 
- Muscle twitching 
- Tremors, convulsions followed by coma and death 
- Treatment 
• Oxygen 
• IV propofol to control convulsions diazepam, thiopentone may 
be used 
• Lipid based solutions which reduces plasma levels. 
Respiratory system: 
• LA drugs depresses hypoxic drive 
• Direct depression of medullary respiratory centre. 
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Immunologic: 
 Allergic reactions are common with esters.  Reactions with amides 
due to its preservative methylparaben . 
Local toxicity: 
 Produce nerve damage when directly injected into the nerve.  When 
directly injected into the muscle it is myotoxic. 
Factors affecting the Height of Block (i.e., Level of Block) 
1. Volume (dosage) of drug: Greater the volume, higher the level of 
block. 
2. Baricity: Baricity is the ratio of specific gravity of an agent at a 
specific temperature (body temperature) to specific gravity of CSF at 
same temperature.  This is very important factor in determining the 
migration and eventual extent of block. 
• Hyperbaric technique: This is the most commonly used method.  
The outcome of hyperbaric spinal anaesthesia is governed by 
position of the patient during spinal anaesthesia and after 
injection till drug gets fixed to neuronal tissue, which normally 
takes 10 to 15 minutes for xylocaine and 20 to 30 minutes for 
bupivacaine. 
• Unilateral spinal anaesthesia: Spinal given in lateral  position and 
patient remains in this position for 5 minutes, hyperbaric solution 
will produce block on one side only. 
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• Hypobaric: Agent used is tetracaine 0.3% which is made by  
hypobaric by addition of sterile water.  It is useful in colorectal 
surgery and applied in prone position where head is lower than 
buttocks (Jack knife position).  The drug will migrate caudally to 
block sacral dermatomes. 
• Isobaric: The commonly used solution is bupivacaine 0.5%.  The 
solution settles at the same level at which it is injected. 
3. Position of patient: It is very important factor.  If the Trendelenburg 
position is given (10 to 20 degree) the same volume will produce a 
much higher level of block. 
4. Intra-abdominal pressure: Increase in intra abdominal pressure by 
ascites, pregnancy, abdominal tumours decreases the volume of 
subdural space and increases CSF pressure, producing higher block. 
5. Spinal curvature: Spinal curvature by effecting the contour of 
subarachnoid space can affect the level of block. 
6. Patient factors: 
a. Age: Old age persons have reduced spinal and epidural space.  So 
higher level is expected. 
b. Obesity: Effects block by increasing intraabdominal pressure. 
c. Height: Taller persons have long spines so require more drug. 
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Factors Not Affecting the Height of Block 
1. Sex: Dosage is same for both males and females. 
2. Speed of injection. 
3. Direction of needle. 
4. Barbotage:  It is the technique in which repeatedly.  CSF is taken out 
and drug is injected. 
Factors Affecting Duration of Block  
1. Dose 
2. Increased concentration. 
3. Pharmacological profile of drug like protein binding, metabolism. 
4. Type of the drug used.  Bupivacaine has prolonged block than 
xylocaine. 
5. Added vasoconstrictors: Although vasoconstrictors increase the 
duration by 10-50% but they should not be used for spinal anaesthesia 
as they can cause ischemia of cord. 
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PRELIMINARY MEDICATION 
 Inadequate premedication during spinal analgesia shows callous 
unconcern for the patient.  It may also wreck the smoothness of an 
otherwise correct technical procedure. 
 In patients over 60 hyoscine may cause excitement and is better 
avoided.  Patients who come to the theatre in an anxious state of mind 
should be helped by further intravenous doses of sedation. 
 Many anaesthetists prefer to give only light premedication, such as 
Atropin with sedative premedication.  
 The phenothiazine drugs give good pre-operative, together with 
prolonged post-operative sedation, but cause, in addition, hypotension 
which may require a pressor drug for its control.   
Armamentarium 
 Sterilization is most important and the whole outfit should be dry 
sterilized by gamma radiation or autoclaved.  All-glass syringes are ideal 
while plastic disposable syringes are excellent.  Sterile distilled water 
must be regarded with suspicion unless it comes from a fresh, previously 
unopened container.  Ampoules should not be stored in spirit or other 
antiseptic solution, as minute faults in the glass may result in 
contamination of the contents with untoward results.  If the autoclave is 
used the hydrochloride salts of lignocaine, mepivacaine, and  show no 
chemical change on gas chromatography.  Boiling for five minutes in 
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water cannot be relied on to kill spores.  Dry heat is not suitable for 
ordinary glass and metal syringes.  Light and heavy cinchocaine solutions 
show decreased potency if autoclaved for more than two hours while 
amethocaine is rather less stable. 
 The lumbar puncture needle should be of fine gauge (22-26 gauge) 
and have a short bevel. 
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PREPARATION 
 
 Before starting regional anaesthesia we must be ready to deal with 
potential complications like total spinal, systemic toxicity following 
accidental intra venous injection of local anaesthetics.  Hemo dynamic or 
airway sequelae.  Regional anaesthesia done only where equipment and 
resuscitation drugs are available immediately includes IPPV with 100% 
oxygen, suction apparatus, airway equipment and drugs used in securing the 
airway and for supporting circulation.  LMA and combitube  should be 
available.  Tilting table is the best one if the patient needs a trendelengburg 
position. 
 A large bored indwelling cannula is placed and around 500 – 100ml of 
lactated ringers solution is given 10 – 20 minutes before induction of the 
block.  The hydration helps to prevent hypotension when symphathetic 
blockade develops.  Infusion is maintained throughout the surgery and post 
operative period. 
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TECHNIQUE OF LUMBAR PUNCTURE  FOR 
INTRADURAL BLOCK 
 The lumbar puncture must be done in  good light on a table which can 
be tilted. 
 Lumbar puncture is contra-indicated in patients with papilloedema or 
cerebral oedema, especially as the result of tumours in the posterior fossa. 
Puncture in Lateral Position. – The patient should be supported by a nurse 
and positioned as follows: 
Back to be at edge of table and parallel to it. 
Knees to be flexed on to abdomen. 
Head to be brought down to knees. 
Hips and shoulders to be vertical to table to avoid rotation of vertebral 
column.  Sudden movement to be avoided. In unilateral operations patient 
should lie on diseased side when hyperbaric solutions, on the sound side 
when hypobaric solutions, are to be used.  In the obese the median crease 
sags downwards sometimes as much as I in., so point of needle should be 
inserted above crease in these cases. 
 The line joining the highest points of the iliac crests crosses either the 
spine of the fourth lumbar vertebra or the interspace between L4 and L5.  
Precise identification of the lumbar spines may be impossible, but this does 
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not matter so long as the first lumbar interspace (and those above this level) 
are avoided.  When the chosen interspace is located the intradermal needle is 
inserted after careful palpation, midway between the two spines, and a small 
weal of local analgesic solution is raised.  The hands of the anaesthetist have 
been scrubbed up and  he has donned a sterile gown and gloves.  The back 
has been painted over a large area with antiseptic and towels arranged 
suitably.  While the skin weal is taking effect, a syringe is filled with 
analgesic solution.  A small incision is made in the skin with a large skin 
needle to prevent a tough skin from grasping the spinal needle tightly and to 
prevent a core of skin being carried into the intra – or extradural space with 
the lumbar puncture needle.  Some prefer to use a Sise or a Rowbotham 
introducer as a cannula through which to introduce the spinal needle.  The 
needle is then slowly pushed forwards parallel to the floor and at right –
angles to the back, with its bevel in the plane to separate and not to divide 
the longitudinal fibres of the dura.  If bone is met, withdraw and slightly alter 
direction either upwards or downwards.  The extradural space can be 
identified in many cases if a drop of analgesic solution is  left on the hub of 
the needle as it is pushed downwards:  the negative pressure of the space 
causes the drop to be indrawn.  From this point, the dura is only a millimeter 
or two away.  When the dura is pierced a click can often be felt.  A 
successful puncture is followed by a free flow of cerebrospinal fluid on 
withdrawal of the stillette.  Flow  must be free, not an occasional drop.  
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Rotation of needle and pushing it in an extra millimeter will often ensure a 
free flow.   Blood-stained cerebrospinal fluid is of no importance and usually 
becomes clear after a few ml have leaked away.  Withdrawal of pure blood 
shows that needle point is probably in a vein, and another puncture must be 
made.  A dry tap is sometimes, but not always, due to failure to introduce the 
needle into the subarachnoid space. 
 Para-median approach easier than the lateral, but if latter is preferred, 
needle is inserted ½ in. from the midline directly opposite the centre of the 
interspace, and the needle is inserted at an angle of 250 to the midline.  With 
this approach, flexion of the back is not so important, it is said to cause 
minimal pain, and tough ligaments are avoided, and so the sense of touch 
and needle control are more accurate.  Sometimes it is successful when 
attempts using median approach have failed.  In very fat patients bony 
landmarks may be impalpable, and in such cases it is a good plan to raise 
three weals in the midline 1cm. apart.  If bone is struck when needle is 
inserted through one weal a successful puncture may be made if the others 
are used in turn.  Another method to facilitate puncture in obese patients has 
been described, the needle entering the relatively large space between the 
fifth lumbar vertebra and the sacrum.  A weal is raised o1cm. medial and 2.5 
cm superior to the medial superior aspect of the posterior superior iliac 
spine: this point is 1.5cm lateral to the midpoint of the lumbosacral 
interspace and from it a needle is advanced 250 to the midline.  This 
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approach may also be used for lumbar extradural blocks.  If the needle 
touches a root of the cauda equine the patient will complain of pain, 
probably in the leg; usually no harm results from this, but if injection of the 
drug causes pain the position of the needle should be slightly altered.  It 
shows that the needle point is within the vertebral canal and has pierced the 
ligamentum flavum.  If failure results from puncture in one interspace it can 
often be made successfully if an adjacent interspace is used. 
Puncture in the sitting position- Many workers find this easier than the 
lateral.  Patient is placed across the table with his feet resting comfortably on 
a stool; spine should be flexed with chin pressed on to sternum.  Flexion of 
the spine rather than flextion of the hips is the aim.  Puncture in this position 
is required for Etherington Wilson’s technique with hypobaric solutions, 
while it is convenient when block of the sacral roots by hyperbaric solutions 
is to be done, although this latter block can be done equally well if the 
puncture is made with the patient in the lateral position, provided that the 
caudal end of the patient is tipped downwards. 
 Puncture in the lumbar region requires no after-treatment other than a 
dab with antiseptic to the skin.  Infection does not occur in the skin and 
subcutaneous tissues. 
Injection of the analgesic drug 
 The prepared solution is drawn up in correct amount into a suitably 
graduated syringe.  It is beneficial to rinse out the syringe first with some of 
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the solution, which is later discarded.  When crystals are used, cerebrospinal 
fluid is allowed to drip into the ampoule, and, after solution has taken place, 
the fluid is re-injected.  During injection, occasional aspiration of a small 
quantity of cerebrospinal fluid confirms that all of the solution reaches the 
subarachnoid space.  The needle should remain in situ for a few seconds 
after injection to prevent leak of analgesic solution through the dural 
puncture hole. 
 If the height of analgesia is to be controlled by the time a patient 
remains tilted, leveling off should take place when sensory loss reaches two 
spinal segments below the desired level.  This allows for a little spread with 
advancing time.  For almost any work inside the abdominal cavity, except 
with the most gentle surgeons, analgesia should reach to the subcostal arch 
(T.6-8), so that the table can be leveled when analgesia reaches the umbilicus 
(T.10).  Upper  abdominal procedures require block to T2-5.  The cough test 
is useful in estimating height of analgesia.  The patient is asked to cough: the 
relaxed part of the abdomen bulges out, and any segment not relaxed 
remains firm and rigid.  Disappearance of the knee-jerks shows block at least 
up to L2. 
Spinal intradural analgesia in non-surgical conditions 
Therapeutic – Patients with autonomic imbalance of the alimentary canal 
such as megacolon, etc.  Relief of the condition by spinal block is an 
indication that sympathectomy may be helpful.  The serial spinal technique 
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of Lemmon is excellent for this high block.  In megacolon, block should 
reach to T.5.  Patients with eclampsia are sometimes benefited by a high 
spinal block up T.8, which reduces their blood-pressure.  Patients with acute 
pulmonary oedema due to left ventricular failure are said to have been 
successfully treated by spinal block, which produces a bloodless phlebotomy 
caused by vasomotor paralysis.  The vasodilatation results in a decreased 
venous return to the right heart and hence to the lungs, relieving left 
ventricular failure.  Renal anuria has been successfully treated by high spinal 
block, which results in dilatation of renal vessels and increased secretion of 
urine. 
Reactionary haemorrhage from prostate bed has been stopped by spinal 
analgesia to S1 which leaves intact the fibres producing vasoconstriction and 
contraction of the prostatic bed (L1 and 2), blocking those fibres (S2,3,4) 
causing dilatation of the vessels and prostatic capsule. 
In cases of embolism of the lower extremity, continuous spinal analgesia 
has been successfully employed, a block to T10 removing the vasoconstrictor 
fibres from the whole leg.  By this means, a block has been maintained for 
50-60 hours.  Continuous spinal analgesia lasting for fourteen days has been 
reported, and that without serious complications.  In such cases, continuous 
extradural analgesia would be better.  If, after many hours, an analgesic drug 
loses its effect, substitution of another drug should be tried. 
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For the treatment of paraplegic clonus in patients who have already lost 
sexual function and bladder control, 5-10ml of absolute alcohol should be 
injected, after 5ml of 5 per cent procaine solution.  This also helps to 
establish the automatic bladder. 
SPINAL ANALGESIA IN INTRACTABLE PAIN – Subarachnoid alcohol 
injection, which was recommended by Dogliotti in 1931 and by G.Todd in 
1937, is sometimes helpful in incurable cases of malignant disease with 
severe pain below the groin and iliac crests, i.e., in the lumbar and sacral 
distribution.  The patient is placed in the semi-prone position with diseased 
side uppermost and head tilted downwards.  Alcohol (abdolute), which must 
be previously autoclaved, is injected between T11 and T12, or T12 and L1, the 
dose being 0.5ml.  The semi-prone position ensures a greater effect on the 
posterior roots than on the anterior with this hypobaric solution.  The 
position must be maintained for one hour.  The beneficial effect may not be 
fully apparent for a week.  About 10 per cent of patients get rectal or bladder 
disability, or weakness of the legs, but this is an improvement on the results 
after chordotomy.  Headache may follow, but subarachnoid adhesions are 
not produced.  The procedure may have to be repeated. 
 When sympathetic fibres alone need to  be blocked, a weak analgesic 
solution can be used, e.g., 0.2 per cent procaine or 0.05 per cent amethocaine 
hydrochloride in distilled water which is hypobaric.  A suitable dose of the 
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latter is 6-12 ml.  (6-12mg) which usually gives a symphathetic block up to 
about T.8. 
 Hypothermic irrigation of the subarachnoid space has been used for 
the treatment of intractable pain, using 10ml of normal saline at 2-40C.  The 
good effects may, however, be due to hyperosmolarity rather than 
hypothermia. 
Intrathecal ammonium sulphate 6 per cent in buffered solution with a pH of 
7.2 is said to block the C type fibres carrying pain impulses from root 
irritation by metastatic  growths in the cord: 3.5ml of the 6 per cent solution 
should be mixed with cerebro spinal fluid and slowly re-injected. 
Phenol (5 per cent) in glycerin and (7.5 per cent) in myodil have been 
injected intrathecally for the treatment of painful reflex spasms and 
spasticity.  Not very effective in long-standing paraplegias with contractures.  
These injections may cause bowel and bladder disturbances and sensory loss 
and should be confined to bedridden patients.  Both solutions are hyperbaric 
and careful positioning is necessary.  Preliminary injection of a  local 
analgesic or of a radio-opaque material will act as a guide to correct 
technique.  The dose of the two solutions varies from 1 to 3 ml.   
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Diagnostic: 
1. INTESTINAL OBSTRUCTION – can be differentiated into organic 
and functional by spinal analgesia; if functional, contraction of the gut, 
with relaxation of sphincters, results in passage of gas and faces within 
twenty minutes.  Differential spinal block using 0.2 per cent procaine 
solution can be used.  This concentration will give paralysis of the 
sympathetic fibres running to the splanchnics, without any sensory (or 
motor) effect.  (Large-bowel nerve-supply : parasympathetic, vagi, 
and S2,3,4-motor; sympathetic, T5 – L3 –inhibitory).  Neither opiates 
nor atropine should be given to these patients, as both drugs inhibit the 
gut. 
2. THROMBO-ANGIITIS OBLITERANS – If the vasoconstrictor fibres 
supplying the lower limbs which come from T10-L2 are blocked there 
is an increase in skin temperature of as much as 80C in normal legs 
and in the vasospastic types of this disease; in the the thrombotic types 
this increase does not take place and further surgery is not likely to be 
beneficial. 
3. DIAGNOSIS OF THE CAUSE OF PAIN IN THE INFERIOR 
EXTREMITY, BACK, AND TRUNK – Injection at 10-min intervals 
of:   
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a. Ten ml of isotonic saline (placebo). 
b. Ten ml of 0.2 per cent procaine in saline (sympathetic block). 
c. Ten ml of 0.5 per cent procaine in saline (sensory block). 
d. Ten ml of 1 per cent procaine in saline (motor block). 
The changes produced are assessed and evaluated as an aid to diagnosis. 
SPINAL INTRADURAL ANALGESIA IN CHILDREN 
 Risk of circulatory depression minimal because of elasticity of their 
cardiovascular systems.  Puncture should be in L3-4 interspace because cord 
extends lower in children than in adults.  Dosage for analgesia to T8 is 10 
mg of procaine for each year; some prefer to use  1mg.  procaine per lb of 
body-weight.  For a newborn baby, 1-2ml of 1-1500 cinchocaine has been 
successfully used, injected through an intravenous needle.  For pyloric 
stenosis in babies, 20mg of procaine in 1 ml cerebrospinal fluid.  Specially 
indicated in shocking procedures, such as open operations on hip-joint; 
useful for operations in the presence of acute respiratory infection, intestinal 
distension, or a full stomach.  Also in hot humid atmosphere, to prevent ether 
convulsions.  Lack of co-operation is chief drawback, so premedication must 
be adequate.  Small doses of morphine, repeated as necessary, make a good 
sedative.  The technique is seldom employed in Britain. 
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COMPLICATIONS OF SPINAL ANAESTHESIA 
Intraoperative 
1. Hypotension:  This is the most common complication.  Mild 
hypotension do occur in almost all patients and significant 
hypotension (systolic BP <90 mm Hg) is seen in 1/3rd of the patients. 
Slight hypotension is beneficial in reducing the blood loss. 
Treatment 
Prophylactic: Preloading with 1 to 1.5 litres of crystalloid (Ringer lactate) or 
500 ml of colloid (Haemaccel) (Colloids are preferred over crystalloids.  
Curative 
i. Head low position (Trendelenburg) to increase the venous return.  
Although the concern of Trendelenburg position is increased chances 
of high spinal and increased ICT but number of studies have proven 
that the beneficial effects overweigh these problems and secondly 
head low up to 150 does not significantly increase the level of block 
and ICT.  So Trendelenburg upto 150 is still the very vital part of 
management for treatment of spinal hypotension. 
ii. Fluids: Colloids are better than crystalloids. 
iii. Vasopressors 
Ephedrine: 2 to 6mg. 
Mephenteramine  
Methoxamine 
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iv. Inotropes (Dopamine, Dobutamine) : Hypotension after spinal is 
because of symphathetic blockade so sympathomimetic drugs 
(ephedrine, mephenteramine) are used in treatment.  The inotrops do 
benefit only indirectly by improving the cardiac output. 
v. Oxygen inhalation (to prevent hypoxia from hypotension) 
2. Bradycardia 
Treatment : Intravenous atropine. 
3. Respiratory paralysis (Apnea) : It is usually because of hypotension, 
so treat hypotension,  it is because of high or total spinal then give 
intermittent positive pressure ventilation (IPPV) with bag and mask or 
intubation.  Slight respiratory difficulty due to lower intercostals 
paralysis is treated by oxygenation and reassurance. 
4. Nausea and vomiting: This is most commonly because of hypotension 
causing central hypoxia.  
Treatment  
• Treat hypotension 
• Oxygenation 
• Antiemetics 
5. Difficulty in phonation: This is because of high spinal extending upto 
cervical level. 
Treatment: IPPV with bag and mask.  Sometimes intubation may be 
required. 
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6. Restlessness, anxiety and apprehension:  Hypoxia should be ruled out.  
Otherwise sedate and reassure may be patient. 
7. Local anaesthetic toxicity:  Due to intravascular injection.  Treat 
symptomatically.  If convulsions occur give diazepam, oxygenate and 
manage any cardiac arrhythmia. 
8. Local anaesthetic toxicity: It is rare. 
9. Cardiac arrest: It can be because of: 
• Severe hypotension 
• Total spinal / very high spinal. 
• Local anaesthetic toxicity/anaphylaxis. 
Immediate start the cardiopulmonary resuscitation. 
10. Broken needle: Attempt the removal at once.  If not possible get a 
portable X-ray and call for neurosurgeon. 
11. Pain during injection. 
12. Blood tap: It can occur because of puncture of epidural vein.  The 
needle should be withdrawn and reinserted. 
Postoperative 
1. Urinary retention: It is due to blockade of S2,3,4, catheterization may 
be required. 
2. Post spinal headache. 
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Clinical features: 
It usually presents after 12-24 hours (corresponds to time when patient starts 
sitting after operation). 
• Usually occipital but can be frontal also.  May be associated with pain 
and stiffness in neck.  It is throbbing and the typical presentation is 
that pain increases on sitting and relieved on lying down. 
• External stimuli like strong light and noise aggravates the pain. 
• Incidence: 3 to 30% (average 13%) it lasts for 7 to 10 days and is 
relieved in almost all cases in 3 weeks (complete healing of dural hole 
takes place in 3 weeks). 
Aetiological factors 
i. Single most important factor is needle size.  Incidence with 16G 
needle may be 75% while with 25G needle it is 1 to 3%. 
ii. Type of needle : Incidence is less with dural separating needle. 
iii. Altitude: High incidence at high altitude. 
iv. Type of patient: Patient with history of headaches are more prone for 
spinal headache. 
v. Inadequate hydration. 
vi. Pregnancy, female gender and young patients have more incidence. 
vii. Incidence is less (statistical significance only) with paramedian 
approach and low glucose concentration of the drug. 
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Cause 
• It is low pressure headache due to seepage of CSF from dural rent 
(hole) created by spinal needle.  The loss may be around 10ml/hr.  
CSF leakage results in changes in hydrodynamics of brain causing 
traction on pain sensitive structures like dura, vessels, tentorium 
producing pain. 
Treatment  
Preventive: 
i. Use of small bore needle. 
ii. Adequate hydration. 
iii. To avoid pillow for next 24 hours. 
iv. If possible, lie in prone position. 
v. Avoiding spinal in patient with history of head ache. 
vi. Avoid sitting in post operative period. 
Curative: 
i. Ask the patient to lie supine in slight Trendelenburg position. 
ii. Analgesics. 
iii. Intravenous fluids (15ml/kg/hr) or oral fluids 3 litres/day.  The aim of 
adequate hydration is to increase CSF production. 
Most often headache is relieved by position, analgesics and adequate 
hydration. 
iv. Abdominal binders. 
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v. Desmopressin: It is antidiuretic and retains fluid in body. 
vi.  Inhalation of 5 to 6% CO2 in oxygen: CO2 is cerebral vasodilator and 
will promote CSF production. 
vii. Oral or intravenous caffeine: 500mg of caffeine in 1 litre of ringer 
lactate inhibits the vasospasm cycle in cerebral vessels. 
viii. Epidural blood patch: 10 to 20 ml of autologous blood is given in 
the same epidural space in which spinal is given.  Blood will clot 
and seal the rent.  Ist blood patch is effective in treating headache 
in 95% patients and 2nd blood patch in 99%.  The blood patch 
should be applied only if other measures fail (15-20ml of blood is 
not likely to cause significant hematoma but can cause transient 
radiculopathy). 
Other causes of headache after spinal anaesthesia: 
• Meningeal irritation: Which is because of chemical meningitis or 
bacterial meningitis.  Headache produced in meningitis is high 
pressure headache and is not related to postural changes. 
• Queckenstedt’s test is employed to differentiate between high 
pressure and low pressure headache.  In this test applying pressure 
on jugular veins increases the headache in former and relieves in 
latter. 
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3. Paralysis of cranial nerves: All cranial nerves except 1st, 9th, 10th can 
be involved after spinal anaesthesia.  Most commonly (90%) 6th nerve 
is involved (because of the longest course of 6th nerve). 
Cause 
• As  a result of low CSF pressure, descent of pons and medulla can 
cause stretching of 6th nerve at the apex of petrous temporal bone. 
Clinical features 
• Paralysis appear after 3rd to 12th post operative day.  Blurred vision, 
double vision, headache, photophobia are the symptoms. 
Treatment: 
Prophylactic: 
• Vigorous hydration. 
• Use of small bore needles. 
Curative: 
• Dark glasses with outer 1/3rd of glass to be made opaque. 
• Muscle exercise. 
• Adequate fluids 
Recovery 
• 50% cases recover in 1 month and most of the cases in 2 years.  If 
recovery is not seen after 2 years surgical correction should be done. 
4. Meningitis 
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a. Aseptic: Chemical meningitis because of antiseptic, solutions like 
betadine, starch powder from gloves, blood drops transported with 
spinal needle. 
b. Infective: Usually due to Staphyloccous epidermidis, carried from skin 
along with needle. 
Treatment: Intravenous antibiotics. 
5. Cauda equine syndrome: Due to direct injury to nerve fibres by trauma 
or by local anaesthetic.  This is usually seen with continuous spinal 
with small bore catheters. 
Clinical features 
• Retention of urine, incontinence of faces, loss of sexual function, loss 
of sensation in perineal region. 
Pathological lesion. 
• Vacuolation of nerve fibres.  Most of these cases recover 
spontaneously. 
6. Chronic adhesive arachnoiditis: Chronic arachnoiditis can cause 
compression of spinal cord, impairing blood supply and causing cord 
ischaemia. 
7. Paraplegia: Due to 
• Epidural haematoma (traumatic spinal). 
• Epidural abscess. 
• Arachnoiditis. 
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• Cord ischemia. 
For epidural haematoma and abscess, neurosurgical intervention 
should be sought immediately. 
8. Spinal cord ischemia: It is due to 
• Severe prolonged hypotension. 
• Use of vasoconstrictors. 
• Epidural haematoma / abscess. 
9. Local toxicity of local anaesthetics: Chloroprocaine can injure spinal 
cord and can cause paraplegia. 
10. Anterior spinal artery syndrome: Epidural haematoma, abscess, 
epidermoid tumour (skin tissue carried with needle  can cause 
epidermoid tumour), can lead to compression of anterior spinal artery 
causing anterior spinal artery syndrome manifested by motor deficit 
without involving posterior columns. 
11. Intracranial complications: Can be 
• Subdural haematoma. 
• Cerebral uncus herniation. 
• Intracranial haemorrhage. 
These are due to changes in hydrodynamics of CSF. 
12. Horner syndrome (with very high spinal anaesthesia). 
13. Local anaesthetic toxicity / anaphylaxis. 
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14. Backache: Many patients report backache after spinal anaesthesis. 
Treatment : Reassurance and analgesia. 
Contraindications: 
Absolute 
1. Raised intracranial tension: Coning can cause death if spinal is given 
to patients with raised ICT. 
2. Patient refusal. 
3. Severe hypovalemia (shock). 
4. Patients on anticoagulants 
5. Patients on thrombolytic / fibrinolytic therapy (spinal not given within 
10 days of receiving these drugs). 
6. Bleeding disorders / cogulopathy. 
In condition 4, 5, 6 there are very high chances of epidural haematoma 
and paraplegia. 
7. Septicemia and bacterimia. 
8. Infection at local site. 
Relative 
1. Fixed cardiac output lesions (AS, MS): These patients can not 
compensate for fall in cardiac output, so should not be given spinal 
(but epidural can be given). 
2. Mild to moderate hypotension and hypovolemia. 
76 
 
3. Uncontrolled hypertension (these patients are very prone to go in 
hypotension). 
4. Severe ischemia heart disease especially history of recent MI. 
5. Heart blocks and patient on β blockers.  Severe bradycardia can occur. 
6. Patient on aspirin. 
7. Patient on minidose heparin subcutaneously (patients on low 
molecular weight heparin IV should be avoided spinal as far as 
possible). 
8. Spinal deformity: Technically difficult. 
9. Previous spinal surgery. 
10. Psychiatric disorders. 
11. History of headaches. 
12. Uncooperative patients. 
13. GIT perforation: Parasympthetic overactivity increases peristalsis and 
can open the seal. 
14. Neuropathies: Important from medicolegal point of view.  If spinal is 
to be given in patient already having neurpathies it is mandatory to 
mention all the deficits in preanaesthetic sheet to avoid any litigation. 
15. CNS disorders.  Both infective and degenerative. 
16. Resistant surgeon. 
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Spinal anaesthesia in children 
• Should be given in lower space (L4-5). 
• Preloading is not required as children less than 8 years are vitually free 
of haemodynamic side effects. 
• Use of narcotics is contraindicated. 
• Chances of systemic toxicity is high. 
Opioids for intra thecal use 
Produces only sensory effect but not preferred.  Because of high chances of 
respiratory depression. 
Morphin: 0.25mg.  Onset is within 20 to 30 minutes and effect lasts for 4 to 
6 hours. 
Fentanyl: 25 µg.  Onset in 5 to 10 minutes and effect lasts for 1 hour. 
Intrathecal ketamine: Preservative free ketamine can be used for spinal but 
effect is short lasting and motor block is not seen. 
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ROPIVACAINE 
    
 
 
 
 
 
History  
 Long acting local anaesthetic bupivacaine was released in 1965.  
Although bupivacaine has been the long acting local anaesthetic of choice 
for decades, when given accidentally it produces irreversible cardio vascular 
collapse.  Cardio toxicity with bupivacaine often proves difficult (or) 
impossible to treat.  Prolonged motor block is another drawback of 
Bupivacaine.  Because of these problems newer agents were looked into and 
Ropivacaine was released in 1996 and only recently launched in India. 
Pharmacology 
 It is amide group of local anaesthetic drug.  It comes in the group of 
mepivacaine and bupivacaine.  Instead of methyl group in mepivacaine 
ropivacaine has a propyl group and bupivacaine has a butyl group.  
Mepivacaine and bupivacaine is currently used clinically as a racemic 
mixture of enantiomers containing equal properties of ‘S’ and ‘R’ forms.  
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But ropivacaine is prepared from the alkylation of S-enantiomer of 
dibenzoil-L-tartaric acid. 
 Pure-S-enantiomer.  It is available as a preservative free clear solution 
in ampoules or vials in concentration of 0.2%, 0.5% and 0.75%.  The 
solution has pH of 4.6 with a pKa 8.1.  It binds extensively with plasma 
proteins (mainly one & acid glycoprotein) metabolized mainly in the liver 
and excreted by the kidneys.  It readily crosses the placenta.  
Pharmacodynamic parameters are similar to other amide agents.  Like other 
local anaesthetic drugs Ropivacaine works by reversible inhibition of Na+ 
ion influx in nerve fibres and thereby temporily stopping electrical 
conduction. 
 It is 10 times less lipid soluble than bupivacaine and hence less likely 
to penetrate large myelinated motor fibres.  It has more selective action on A 
and C fibres as compared to A fibres.  It has a less depression of cardiac 
conductivity and QRS interval.  It is available as only isobaric solution. 
Isobaric verses Hyperbaric 
 Density of a solution is the weight  in gms of 1ml of that solution at 
370C. 
 Specific gravity is the ratio of the density of the solution with the 
density of the water.  
 Baricity is the ratio comparing the density of the one solution to 
another. 
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 To make a drug hypobaric to CSF it must be less dence than CSF 
i.e.1,0000 
 By adding water and warming the drug to 370C from 40C it becomes 
hypobaric. 
Dose: 
 Upto 3mg per kg. 
 Based on patient. 
 Route of administration and type of surgery. 
Contraindication: 
 Allergy to amide LA 
 Bier’s block. 
Uses: 
 Epidural / caudal block 
 Intra thecal block 
 Nerve block 
 Local infiltration 
 Local instillation 
To establish a surgical anaesthesia through an epidural 10 – 20mls of 0.5% 
to 0.75% Ropivacaine is used depending on patient size and height of the 
block required.  For postop and labour pain relief using an epidural 10mls/hr 
of 0.2%.  Ropivacaine with fentanyl 2-4mg/ml can be used. 
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 When used in epidural infusions 0.2% Ropivacaine is used for nerve 
blocks is fast with the motor block wearing off much earlier than compared 
to Bupivacaine. 
 It is available as only Isobaric solution.  Spinal Ropivacaine (0.75%) 
2.5 – 4mls with additives like Fentanyl and clonidine offers a reliable cardio 
stable anaesthesia of the lower abdomen and limbs.  Speed of onset is slower 
compared to Bupivacaine. 
 For the same volume intra thecal, height of the block with isobaric 
Ropivacaine 0.75% is significantly lower as compared to hyperbaric 
Bupivacaine (0.5%) Addition of clonidine, Dexmedetomidine prolongs 
analgesia upto 16hrs (Beware Bradycardia). 
 Safety of Ropivacaine has been studied extensively.  In a classic 
canine study (aroban 2001) open chested dogs were randomized to escalating 
infusion of Bupivacaine, levobupivacaine and Ropivacaine to the permit of 
cardiovascular collapse. 
 Unsuccessful resuscitation from Bupivacaine, levobupivacaine, 
Ropivacaine was 50%, 30% and 10%.  Larger doses and blood 
concentrations of Ropivacaine was tolerated compared to Bupivacaine and 
levobupivacaine.  Several studies and case reports have also established the 
safety of the Ropivacaine. 
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 Ventricular arrhythmias and fatal ventricular fibrillation may occur 
more often after the rapid intra venous administration of large dose of 
bupivacaine. 
 The pregnant patient is more sensitive to cardiotoxic effects of 
bupivacaine.  0.75% bupivacaine is no longer recommended for use in 
obstetric anaesthesia. 
 There is no established role of antiarrhythmic drugs or traditional 
drugs in the setting of bupivacaine induced cardiac arrest.  The first 
treatment for accidental intra vascular injection of overdose of anaesthetic 
are 
- Securing the airway 
- Oxygenation, ventilation 
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DEXMEDETOMIDINE 
 
α2 receptors present in the sympathetic nerve endings and no 
adrenergic neurons in the central nervous  system.  Administration of 
α2 agonist has been shown to have several beneficial action during the 
perioperative period.  Clonidine is the α agonist which is used for long 
time. 
 Dexmedetomidine is the recently released IV anaesthetic.  In 
December 1999, it was approved for the clinical practice.  It is a highly 
selective α2 receptor agonist that has been shown to have both sedative and 
analgesic effects in adults.  It has an α2 to α1 receptor agonist ratio of 1600:1,  
which is 7-8 times higher than reported for clonidine.  The ratio favors the 
sedation, anxiolytic action rather than the hemodynamic actions seen in the 
same class of α2 receptor agonists such as clonidine. 
Chemical structure of dexmedetomidine      
 
 
 
 
 
 
84 
 
Pharmacology: 
 It is available as injection form.  If it is given it rapidly distributed, 
metabolized and excreted in urine and feces.  It is 94% protein bound.  The 
elimination half life of dexmedetomidine in 2-3hrs with CSHT 4 minutes 
after an infusion. 
α receptors: 
 They are G-protein coupled receptors.  It inhibits adenyl  cyclase and 
modulation channels.  Three types of α2 receptors noted noted α2A, α2B, α2C.  
α2B & α2C receptors are situated in the CNS and spinal cord.  α2A receptors 
are located in the periphery. 
 The overall response to the α2 receptor agonist is sympatholysis, 
sedation, and antinociception. 
CNS action: 
Sedative and hypnotic 
 It acts on α2 receptors situated in locus ceruleus in the CNS and spinal 
cord.  Has limited respiratory depression providing wide margin of safety.  
This character is useful for daily wakeup test to asses the mental status and 
titration of dosage of sedation.  It decreases the activity of the locus ceruleus 
and increases GABA and galamin release.  It also decreases the histamine 
release in cortical and subcortical areas. 
 Their advantage is actions are reversible with antagonist. 
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Analgesic effect: 
 When given through intra thecal and epidural route it gives analgesic 
effect.  It reduces blood pressure.  It acts on spinal cord to produce analgesic 
effect.  It reduces opioid requirement.  Evidence based medicine says that it 
lowers neuro and histopathological damage during periods of cerebral 
ischiemia.  It reduces excitating neurotransmitters and moderate actions of 
anti apoptotic protein.  In craniotomies it is very well used because it has 
very minimal action on evoked potentials. 
Respiration 
 It preserves ventilator response to hypercapnia and reduces histamine 
induced bronchoconstriction.    Respiratory rate is increased and minute 
ventilation decrease in clinical concentrations. 
CVS action: 
• Decreases heart rate. 
• ↓es peripheral vascular resistance 
• ↓es cardiac output 
• ↓es blood pressure 
It will increase Bp initially by vasoconstrictive response.  Severe 
bradycardia reported and is easily reversible with atropine.  It 
decreases myocardial O2 consumption.  Dry mouth is a one of its side 
effect. 
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Clinical uses: 
• ICU sedation 
• It decreases opioid requirement 
• Hemodynamic stability is maintained in weaning patients 
• Anxiolytic 
• Used in alcohol withdrawl syndrome and drug withdrawl 
• Gives adequate sedation without respiratory depression. 
Uses in anaesthesia: 
Used as a premedicant 
• Reduces dosage of anaesthetic drugs like  
opioids and  
thropentone and  
volatile agents 
• Reduces stress response to intubation 
• Post operative shivering is reduced very much 
• Has been used for monitored anaesthesia care. 
• It is used as adjunct in subarachnoid block. 
• Recent study reports say that it improves the quality of anaesthetic 
drug. 
• ↓es intra and post operative analgesic requirement. 
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REVIEW OF LITERATURE 
• S.Kurdi medhuri and kumara B.Anjali in J.Anaes clinical 
pharmacology 2010 Oct-Dec: 26(4) 564 telling that 0.75% 
Ropivacaine provides reliable, adequate and safe sensory and 
motor blockade. 
• M.Wille, Acta Anaes.  Belg.2004.55.251-259.  Says that 
Ropivacaine have demonstrated good tolerability and efficacy 
without any hemotoxic efforts. 
• Ragini Gupta et al Ind.J.Anaes 2011/vol 55/Issue 4 page 347-
351. 
Say that addition of Dexmedetomidine with Ropivacaine.  
Prolongs duration of Analgesia. 
• Ashrag Amin Mohamed et al. pain physician 2012; 15: 339-
348, ISSN 1533 – 3159 tell that Dexmedetomidine improve 
quality and duration of post operative analgesia. 
• G.E.KANAZI et al Acta Anaes. Scand 2006;50: 222-229 
dexmedetomidine when added to intra thecal local analgesia 
produces prolongation of diameter  of sensory and motor 
blockade and give hemodynamic stability. 
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• Yamashita A et al (18) Matsumoto M, Matsumoto S, Itoh M, 
Kawai K, Sakabe T.A compared the neurotoxic effects on the 
spinal cord of terracaine, lidocaine, bupivacaine, and 
ropivacaine administered intrathecally in rabbits reported no 
neurodeficit. 
• Kalso et al (22) Reported that dexmedetomidine affecting to α2 
receptor agonists is 10 times compared to clonidine. 
• Al-Ghanem et al (34) have reported the use of 
dexmedetomidine is associated with decrease in HR & BP. 
• Yoshitomi et al (72) say that dexmedetomidine enhances the 
local anaesthetic action via an alpha-2A receptor. 
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MATERIALS AND METHODS 
Study design:  This was a randomized, prospective double blind 
comparative clinical study. 
Randomization: 
 Simple randomized sampling was done by computer generated 
random numbers. 
Sample size: 
 Sixty patients were studied. 
Inclusion criteria: 
• Age between 30 – 60 years and only male cases. 
• ASA I & II cases  
• Weight 40 – 65 kg 
• Elective surgeries (Inguinal hernioplasty) 
Exclusion criteria:  
• Patient refusal 
• Known allergy  
• Coagulopathy 
• Patient on β blockers 
• Patient on long term analgesic therapy 
• Patient on drugs which are known to interact with study drugs 
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Allocation 
 After obtaining Institutional Ethical committee Clearance and 
written informed consent, the patients were randomly allocated into 2 
groups. 
• Group 1 (30 patients) 
• Group 2 (30 patients) 
Spinal administration of drug mixture 
1. Group 1 = 0.75% Isobaric Ropivacaine 3mls + 0.5ml normal 
saline (Total volume 3.5ml) 
2. Group 2 = 0.75% Isobaric Ropivacaine 3ml + 5mcg (.05ml) 
dexmedetomidine in 0.45ml normal saline (Total volume 3.5ml) 
Masking: 
 The anaesthesiologist who administered the drug and the observer 
were blinded to the study.  Sterile syringes containing 3.5ml of total volume 
of the drug were loaded by another anaesthesiologist not participating in the 
study.  The intra operative monitoring and post operative observation was 
done by the same anaesthesiologist who administered the drug, but was 
unaware of the contents of the syringes. 
Preoperative evaluation: 
1. History 
2. Clinical examination 
3. Airway assessment 
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4. Blood biochemistry 
5. X ray chest 
6. Electrocardiogram 
Procedure: 
Premedication: 
 The patients in both the groups were given inj.Glycopyrrolate 
0.2mg and midazolam 2mg i.m. 45 min before surgery. 
 Patients were preloaded with Ringer’s lactate – 15ml per kg. 
 The cases were started after checking the emergency drugs and 
equipment for resusitation. 
 30 cases from each group were taken up for study.  In each 
group one case was converted to general anaesthesia because of failure 
of spinal block.  That case was excluded from the study. 
 29 cases in each group were taken up for statistical analysis.   
  Subarachnoid block was performed by using 25  g  Quinkes needle 
with the patient in right lateral position at L3 L4 space. The study drug 
was administered according to allocated group.  Ropivacaine 0.75% 
3ml and 0.5ml normal saline in 30 cases and Ropivacaine 0.75% 3ml 
and 0.5ml normal saline with 5 microgram dexmedetomidine in 30 
cases. 
 Immediately after performing the block patient were turned 
supine.    
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After the block pulse rate, BP and SPO2 monitoring was done in 
3, 5, 15, 30minutes then  every 30 minutes.  Onset of sensory block 
and level was seen by stillette of spinal needle by pinprick sensation.  
Onset of motor block was assessed by the Modified Bromage scale. 
 Intra venous fluids was given intra operatively and post 
operatively about 100 – 150ml per hour.  Sensory level T7 – T8 was 
achieved in all cases that was adequate for doing hernia surgery.  
 Supplimental  oxygen was given by mask throughout the 
surgery in all the cases. 
 Ephedrine was given when more than 20% fall in baseline 
systolic blood pressure.  Atropine was given when pulse rate less than  
60 per minute.  It was required in group 2 cases. 
 Post operatively patients were kept in recovery room for 4 hours 
and then shifted to the ward. 
 Two segment regression and S2 segment regression time were 
noted.  Duration of analgesia was taken when visual analogue scale 
score more than 4 and motor duration was taken when modified 
bromage scale ‘O’ i.e. full power. 
 Rescue analgesia given time was noted for analgesia duration.  
Patients were observed for 2 post operative days for complications.  
One patient developed headache and relieved by giving intra venous 
fluids. 
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OBSERVATION AND RESULTS 
 
“A STUDY OF CLINICAL EFFECTS OF INTRATHECAL 
ROPVACAINE AND ROPVACAINEWITH DEXMEDETOMDINEIN 
INGUINAL HERNIA CASES” 
Statistical Analysis: 
 The two groups were matched according to their base line 
characteristics of continuous variables by Students’ independent ‘t’ test. And 
the categorical variables between two group were matched by χ2 (Chi-
square)  test. The on set sensory block, motor block and rescue of analgesia 
and motor block duration were compared between two groups. The analysis 
and interpretations were performed by IBM SPSS statistics 20. The P- values 
lessthan 0.05 (P< 0.05) were defined as statistically significant in two tailed 
test. 
Results and observation: 
Matching of the two groups;  
 The two groups were matched in respect of their demographic 
characteristics such as age and weight. The base line clinical variables such 
as ASA grade, Pulse rate, SBP, DBP, Sensory and Motor block were 
matched between the two groups.  
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Table-1. Matching of age between two groups. 
Age (years) 
Ropivacaine =1 Ropivacaine and Dexmed=2 
No % No % 
30-39 10 34.5 5 17.2. 
40-49 6 20.7 17 58.6 
50-59 13 44.8 7 24.2 
Total 29 100.0 29 100.0 
Mean±SD 45.1±8.6 45.0±4.9 
Significance t=0.019, df=56 and P>0.05 
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Table-2. Matching of Weight between two groups. 
Weight  (Kg) 
Ropivacaine =1 Ropivacaine and Dexmed=2 
No % No % 
40-45 1 3.4 2 6.9 
45-50 11 37.9 13 44.8 
50-55 6 20.7 12 41.4 
55-60 7 24.2 0 0.0 
60-65 4 13.8 2 6.9 
Total 29 100.0 29 100.0 
Mean ± SD 51.3±5.3 49.6±4.0 
Significance t=1.396, df=56 and P>0.05 
 
The two groups were not significantly differed in respect of their mean ages 
(45.1±8.6 = 45.0±4.9). Similarly they were also not significantly differed 
between the mean weights of two groups (51.3±5.3≈49.6±4.0 and P>0.05). 
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Table-3.Matching of base line PR, SBP and DBP between two groups.  
 
Variables 
Ropivacaine 
=1 
Ropivacaine and 
Dexmed=2 
Difference
b/w means
‘t’ df Signi 
Mean SD Mean SD 
PR 86.9 8.9 84.5 9.3 2.4 1.010 56 P>0.05 
SBP 121.3 8.3 120.3 5.9 1.0 0.547 56 P>0.05 
DBP 78.6 4.4 79.3 2.6 0.7 0.727 56 P>0.05 
 
The base line PR, SBP, and DBP were matched and shown in the above 
table-3. The mean PRs between the two groups were not statistically 
significant (86.9±8.9 ≈ 84.5±9.3 and P>0.05). The mean SBPs between the 
two groups were not statistically significant (121.3±8.3 ≈ 120.3±5.9 and 
P>0.05). ). The mean DBPs between the two groups were not statistically 
significant (78.6±4.4 ≈ 79.3±2.6 and P>0.05). 
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Table-4.  Matching of sensory level between two groups. 
 
Sensory 
level 
Groups 
χ2 Df Signi 
1 2 Total 
T7 6 10 16 
1.381 1 P>0.05 T8 23 19 42 
Total 29 29 58 
     The above table states the base line sensory block between the two 
groups. The two groups were not significantly differed between them 
(P>0.05).  
Table-4. Matching of sensory level 
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Table-5. Matching of ASA Grade between two groups. 
ASA 
grade 
Groups 
χ2 df Signi 
1 2 Total 
I 25 26 51 
0.162 1 P>0.05 II 4 3 7 
Total 29 29 58 
      
The above table -5 describes the base line ASA grade between the two 
groups. The two groups were not significantly differed between them 
(P>0.05).   
The two groups namely Ropivacaine (1) and Ropivacaine and 
Dexmedetomidine (2) were not significantly differed at base line and hence 
they were comparable during and after surgery. Two groups Motor blocks at 
base was 3 in both groups. 
Comparison of two groups during and after surgery: 
  The two groups were compared during and after surgery to study the 
effectiveness of two drugs at different intervals in respect of sensory and 
motor blocks on set.  
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Table-6.On set of Sensory blocks (T10) and Motor blocks(2) between two 
groups. 
Blocks Group-
1(Mts) 
Group-2(Mts) Difference 
b/w means ‘t’ df Sig. 
Mean SD Mean SD 
Sensory 8.0 1.8 5.58 3.56 2.42 3.31 56 P<0.005
Motor 10.14 5.2 5.37 3.6 4.77 5.30 56 P<0.001
 
The mean on set of sensory blocks between the two groups was statistically 
significant (P<0.005). The mean on set of Motor blocks between the two 
groups was statistically significant (P<0.001). 
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Table-7. Comparison of Pulse rate at different interval between the two 
groups. 
Intervals Group-1 Group-2 Difference 
b/w means
‘t’ df Sig. 
Mean SD Mean SD 
3 Mts 91.8 13.8 92.0 13.5 0.2 0.058 56 P>0.05 
6 Mts 89.3 13.7 83.4 12.9 5.9 1.680 56 P>0.05 
15 Mts 79.8 14.4 75.0 17.2 4.9 1.176 56 P>0.05 
30 Mts 81.1 12.8 76.9 14.3 4.2 1.180 56 P>0.05 
1 Hr 82.0 9.0 81.1 5.2 09 0.397 56 P>0.05 
2 Hrs 86.3 103 83.9 7.3 2.4 1029 56 P>0.05 
4 Hrs 113.6 9.0 89.8 8.0 23.8 10.469 56 P<0.001
8 Hrs 107.2 7.3 112.3 11.3 5.1 2.072 56 P<0.05 
 
The above table-7 shows the pulse rate at different interval starting from 3 
minutes to 8 hours. From 3 minutes to 2 hours there was no significant 
difference between the two groups. At 4 hours the pulse rate among the 
group 1 subjects was significantly greater than the group 2 and the same was 
attributed to the risk of rescue analgesia. At 8 hours the pulse rate was 
greater in group 2 due to the above reason. 
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Table-8. Comparison of SBP at different interval between the two groups. 
Intervals Group-1 Group-2 Difference 
b/w means 
‘t’ df Sig. 
Mean SD Mean SD 
3 Mts 121.4 9.8 120.5 6.8 0.9 0.404 56 P>0.05 
6 Mts 118.9 8.6 115.2 4.2 3.7 2.097 56 P>0.05 
15 Mts 111.9 10.1 108.8 1.9 3.1 1.625 56 P>0.05 
30 Mts 109.0 9.7 106.8 2.7 2.3 1.212 56 P>0.05 
1 Hr 111.2 6.2 109.5 2.5 1.7 1.386 56 P>0.05 
2 Hrs 112.5 5.7 113.9 4.5 1.4 1.075 56 P>0.05 
4 Hrs 128.3 4.9 114.7 4.0 13.6 11.568 56 P<0.001
8 Hrs 117.4 5.6 128.9 5.0 11.5 8.232 56 P<0.05 
 
The above table-8 shows the SBPat different interval starting from 3 minutes 
to 8 hours. From 3 minutes to 2 hours there was no significant difference 
between the two groups. At 4 hours the pulse rate among the group 1 
subjects was significantly greater than the group 2 and the same was 
attributed to the risk of rescue analgesia. At 8 hours the pulse rate was 
greater in group 2 due to the abovereason. 
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Table-9. Comparison of  DBP at different interval between the two groups. 
 
Intervals Group-1 Group-2 Difference 
b/w means 
‘t’ df Sig. 
Mean SD Mean SD 
3 Mts 77.2 7.0 76.9 5.4. 0.3 0.209 56 P>0.05 
6 Mts 75.5 6.9 76.6 4.8 1.0 0.664 56 P>0.05 
15 Mts 70.0 7.6 70.0 0.0 0.0 0.0 56 P>0.05 
30 Mts 71.0 6.6 66.6 4.8 4.4 2.898 56 P>0.05 
1 Hr 69.7 4.9 69.7 1.8 0.1 .071 56 P>0.05 
2 Hrs 70.4 4.4 73.1 4.7 2.7 2.235 56 P>0.05 
4 Hrs 78.4 7.4 73.1 4.7 5.3 3.244 56 P<0.001
8 Hrs 73.0 6.1 83.4 4.8 10.4 7.214 56 P<0.05 
 
The above table- shows the DBP at different interval starting from 3 minutes 
to 8 hours. From 3 minutes to 1 hour there was no significant difference 
between the two groups. At 4 hours the pulse rate among the group 1 
subjects was significantly greater than the group 2 and the same was 
attributed to the risk of rescue analgesia. At 8 hours the pulse rate was 
greater in group 2 due to the above reason. 
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Table- 10. Comparison of Rescue analgesia between two groups.  
 
  
Variable 
Group-1 Group-2 Difference 
b/w means
‘t’ df Sig. 
Mean SD Mean SD 
Rescue 
analgesia 
217.2 17.5 453.1 20.2 235.2 47.525 56 P<0.001
 
The above table -10 shows the analgesia of two groups The mean analgesia 
of group 2 was 453.1±20.2 and group 1 was 217.2 ± 17.5. The group 2 
patients had longer duration of analgesia than the group 1 patients. 
(453.1±20.2>217.2 ± 17 and P<0.001). 
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 Survival of Analgesia between two groups 
 
The above Figure  illustrates the significance of longer duration of analgesia  
of group-2 than the group-1. 
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Table-11. Comparison of two segment regression and S2 regression between 
the Groups.  
 
  Variable Group-1 Group-2 Difference 
b/w means
‘t’ df Sig. 
Mean SD Mean SD 
2 segment 
regression 
89.0 18.2 131.7 11.4 42.8 10.735 56 P<0.001
S2 
regression 
243.1 20.2 297.9 25.3 54.8 9.128 56 P<0.001
 
The above table -11 shows the two segment regression and S2 regression of 
two groups. The mean two segment regression of group 2 was 131.7±18.2 
and group 1 was 89.0 ± 18.2. The group 2 patients had longer duration of 
two segment regression than the group 1 patients (131.7± 11.4>89.0±18.2 
and P< 0.001). Similarly, S2 regression was also significantly greater in 
group -2 than  in group-1 (297.9±25.3 > 243.1±20.2 and P< 0.001).  
 
 
 
 
 
107 
 
 
 
Table12 Comparison  between two groups in Motor block duration in hours 
 
  
Variable 
Group-1 Group-2 Difference 
b/w means 
‘t’ df Sig. 
Mean SD Mean SD 
Motor 
Duration  
2.63 0.41 3.94 0.38 1.31 0.02 56 P>0.05 
 
The above table shows motor block durations between two groups. In Group 
-2 patients had long duration of blockade (3.94+ 0.38>2.63+ 0.41 P> 0.05) 
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DISCUSSION 
 Sub arachnoid block is a simple, frequently used technique 
which provides very effective analgesia in lower abdominal surgeries  
and lower limb surgeries.  Ropivacaine is a newer drug with a more 
safety margin with reduced risk of cardiotoxicity.  Dexmedetomidine  
is an 2 agonist which is very much used  nowadays as an additive 
with local anaesthetics.  It gives intra operative and post operative 
analgesia with a single dose of sub arachnoid block.   This study was 
done keeping this point in mind.  Moreover it is devoid of opioid side 
effects, but may produce sedation, bradycardia, hypotension. 
 Onset of sensory and motor block was early in group II patients 
than group I ( group II   5.58 ± 3.56 > 8.0 ± 1.8 in group I ) with the 
‘P’ value < 0.05. 
 Bradycardia and hypotention are the known features of 
subarachnoid block.  In this study in group II patients out of 29 
patients 2 patients were developed bradycardia with hypotention and 
they required atropine and ephedrine. 
 No patients have developed any nausea or vomiting in both 
groups.  But in group II, patients were free of anxiety and comfortable.  
Both groups didn’t require any sedation intra operatively. 
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 Post operatively group II patients had delayed two segment 
regression and S2 segment regression, than group I patients.  (‘P’ 
value  < 0.001). 
 It was observedthat motor block duration was more with group 
II patients than group I (‘P’ value  > 0.05 ). 
 It was noted that time of getting rescue analgesia was very 
much delayed in group II than group I (‘P’ value  <0.001).    
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SUMMARY 
 
  It was found that intrathecal ropivacaine in this study produces 
T7 – T8 level of sensory blockade with adequate motor blockade for 
hernia surgery and patients were hemodynamically stable. 
 With group 2 patients early onset of sensory and motor 
blockade and delayed recovery from sensory blockade and motor 
blockade noted  with the risk of getting bradycardia and hypotention.  
But patients were  more comfortable (free of anxiety) in this group 2 
than group 1. 
 Only one patient developed PDPH which was relieved by intra 
venous fluids. 
 
 
 
 
 
 
 
 
111 
 
 
 
CONCLUSION 
 
 Ropivacaine is a newer ideal, safe anaesthetic of choice for intra 
thecal use in inguinal hernia surgery cases, (ASA I & II) and by 
adding dexmedetomidine we get prolongation of analgesia. 
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PROFORMA 
 
A STUDY OF CLINICAL EFFECTS OF INTRATHECAL 
ROPIVACAINE & ROPIVACAINE + DEXMEDETOMIDINE 
IN INGUINAL HERNIA CASES 
 
NAME DATE AGE  SEX   WARD 
 
SURGEON ANAESTHESIOLOGIST 
 
 
ASA GRADE    STUDY GROUP A / B 
 
 
PRE OPERATIVE CONDITION: 
 
PR  BP  Hb%   BT.CT 
 
 
Blood Sugar  Urea  Creatinine  Chest X-Ray 
 
 
ECG  CVS   RS   Airway 
 
 
Blood Grouping: 
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ANAESTHETIC PLAN 
PRE LOADING: 
SUB ARACHNOID BLOCK: 
Drug: 
 
Dossage: 
 
Needle: 
 
Position: 
 
Level: 
 
No of Attempts: 
 
ASSESSMENT OF LEVEL OF BLOCK 
Autonomic level: 
 
Sensory level: 
 
Motor Blockade: 
Modified Bromage Scale:  0 1 2 3 
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SPINAL DERMATOMOL LEVEL OF BLACKADE TIME 
 
 
Time Sensory Motor 
3MTS   
5MTS   
10MTS   
15MTS   
30MTS   
45MTS   
60MTS   
80MTS   
100MTS   
120MTS   
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TIME PR BP SPO2 RR GI Symptom Sedation Pruritus VAS 
3MTS    
5MTS    
10MTS    
15MTS    
30MTS    
45MTS    
60MTS    
80MTS    
100MTS    
120MTS    
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POST OPERATIVE 
VAS  for   Analgesia Assessement 
Motor MBS 
Time            BP                 PR         Analgesia                      Motor Blockade 
       
       
       
       
       
       
       
       
 
TIMING OF RESCUE ANALGESIA  
 Duration of Analgesia: 
 
TWO SEGMENT REGRESSION TIME: 
S2 SEGMENT REGRESSION TIME: 
 
 
 
129 
 
STUDY GROUP 
(A)  INTRATHECAL ROPIVACAINE 
0.75% 3ml + 0.5ml of NS 
(B)  INTRATHECAL ROPIVACAINE 
0.75% 3ml + 0.5ml of NS with 5 Microgram of 
dexmedetomidine 
1. AUTONOMIC LEVEL     TESTED BY APPLICATION OF SPIRIT 
2. SENSORY LEVE      PIN PRICK SENSATION 
    BLUNTED NEEDLE / 
3. MODIFIED BROMAGE SCALE FOR MOTOR BLOCKADE 
0 Full Power 
1 Unable to straighten the leg 
   Just able to Flex knees 
2 Foot Movement only. 
3 Loss of power – No movement 
VISUAL ANALOG SCALE 
1        2           3         4          5          6           7           8          9           10 
  
VERBAL RATING SCALE 
   
   0 None 
   1 Mild 
   2 Moderate 
   3 Severe 
   4 Very severe Intolerable Pain 
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MASTER CHART 
Group,1=Repiva,2=Repiva+De
xmedet 
Sl.N
o 
Ag
e 
Weig
ht 
TS
A 
Ba 
PR 
Ba 
SB
P 
Ba 
SB
P 
Se
n 
bl
o 
Mo
t 
Se
n 
tim
e 
Se
n 
lev 
Mot 
Tim
e 
Mo
t 
lev 
PR 
3 
Mit
s 
PR 
6 
Mit
s 
PR 
15 
Mit
s 
PR 
30Mi
ts 
1 1 36 48 I 
10
0
12
0 80 T8 3 9 T8 12 2 100 96 92 96
1 2 56 46 I 
10
0
12
0 80 T8 3 9 T8 3 2 100 96 92 96
1 3 50 50 I 70
10
0 60 T8 3 6 T8 12 2 68 66 60 80
1 4 50 58 I 94
13
0 80 T8 3 9 T7 3 2 90 80 64 80
1 5 50 55 I 80
13
0 80 T8 3 3 T8 12 2 90 96 80 78
1 6 38 48 I
10
0
12
0 80 T7 3 9 T8 12 2 96 86 68 76
1 7 52 56 I 
10
8
12
0 80 T8 3 9 T8 9 2 108 108 104 102
1 8 48 50 II 70
10
0 80 T8 3 6 T8 9 2 68 66 60 60
1 9 38 55 I 
10
8
12
0 80 T8 3 9 T7 12 2 90 96 80 78
1 10 56 46 II 
10
6
12
0 80 T8 3 9 T8 12 2 90 96 84 88
1 11 50 56 I 
10
0
13
0 80 T8 3 9 T8 6 2 96 86 64 68
1 12 52 60 II 78
13
0 80 T8 3 6 T8 6 2 72 78 86 90
1 13 40 44 I 
10
0
13
0 80 T7 3 9 T8 9 2 110 106 100 98
1 14 48 50 I 72
12
0 80 T8 3 6 T8 6 2 70 68 64 68
1 15 36 50 I 90
12
0 80 T8 3 9 T8 9 2 110 106 102 96
1 16 40 45 I 90
12
0 80 T7 3 6 T7 12 2 90 94 64 68
1 17 32 60 I 90
13
0 80 T8 3 9 T8 12 2 90 90 80 68
1 18 32 60 I 96
12
0 80 T8 3 9 T8 12 2 90 88 82 86
1 19 55 48 I 90
12
0 80 T8 3 6 T8 6 2 92 80 66 70
1 20 38 48 II 
11
0
12
8 80 T8 3 9 T8 9 2 110 106 100 102
1 21 58 45 I 96
12
0 80 T7 3 9 T7 9 2 78 74 68 64
1 22 50 60 I 96
12
0 80 T8 3 9 T7 9 2 78 74 68 68
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1 23 52 56 I 
11
0
13
0 80 T8 3 3 T8 12 2 108 100 98 96
1 24 36 55 I 90
12
0 80 T8 3 9 T8 12 2 100 102 82 76
1 25 34 52 I 80
11
0 70 T8 3 9 T8 9 2 90 86 80 80
1 26 48 48 I 80
11
0 70 T8 3 9 T8 6 2 68 66 60 64
1 27 32 50 I 90
12
0 80 T8 3 9 T7 12 2 110 106 98 96
1 28 42 45 I 
10
8
13
0 80 T7 3 9 T8 6 2 108 108 90 86
1 29 58 45 I
10
0
13
0 80 T7 3 9 T8 9 2 92 86 80 74
2 1 45 50 I 80
12
0 80 T7 3 3 T7 6 2 76 70 60 64
2 2 44 54 I 80
12
0 80 T8 3 3 T8 3 2 108 100 98 96
2 3 46 48 I 80
12
0 80 T7 3 3 T8 6 2 76 70 60 64
2 4 48 44 I 80
12
0 80 T8 3 3 T8 3 2 108 100 98 96
2 5 38 45 I 80
12
0 80 T8 3 3 T7 3 2 108 100 98 96
2 6 54 50 I 82
13
0 80 T7 3 3 T8 6 2 76 70 60 64
2 7 39 44 I 80
11
2 80 T7 3 6 T7 6 2 76 70 60 64
2 8 44 45 I 80
11
2 80 T8 3 6 T8 3 2 108 100 98 96
2 9 40 52 II 76
11
6 80 T7 3 6 T8 6 2 76 70 60 64
2 10 40 48 I 76
11
6 80 T7 3 6 T7 6 2 76 70 60 64
2 11 47 49 I 80
12
0 80 T8 3 6 T8 3 2 108 100 98 96
2 12 48 48 I 80
12
0 80 T7 3 6 T8 6 2 76 70 60 55
2 13 52 48 I 92
13
0 80 T8 3 9 T8 3 2 92 80 66 70
2 14 45 45 II 80
12
0 80 T8 3 3 T8 6 2 108 100 98 96
2 15 48 60 I 80
12
0 80 T8 3 3 T7 3 2 108 100 98 96
2 16 50 50 I 80
12
0 80 T8 3 3 T8 3 2 108 100 98 96
2 17 44 52 I 76
11
6 80 T7 3 9 T8 6 2 76 70 60 64
2 18 47 48 I 80
12
0 80 T8 3 9 T8 3 2 108 100 98 96
2 19 38 52 I 92
13
0 80 T8 3 6 T7 6 2 92 80 66 70
2 20 38 48 I 76
11
6 80 T7 3 6 T7 3 2 76 70 60 64
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2 21 50 50 I 76
11
0 80 T7 3 6 T8 3 2 76 70 60 54
2 22 33 48 I 76
11
0 70 T8 3 9 T8 6 2 108 100 98 96
2 23 45 50 I 92
12
0 70 T8 3 3 T8 3 2 92 80 66 70
2 24 50 60 I 92
13
0 80 T8 3 3 T7 3 2 92 80 66 70
2 25 47 48 I
10
0
12
0 80 T8 3 3 T8 6 2 92 80 66 70
2 26 42 45 I 98
12
0 80 T8 3 9 T7 3 2 92 80 66 70
2 27 50 52 II
10
6
12
0 80 T8 3 6 T8 12 2 92 80 66 70
2 28 50 54 I 
10
8
13
0 80 T8 3 6 T8 12 2 92 80 66 70
2 29 44 52 I 92
13
0 80 T8 3 6 T7 12 2 92 80 66 70
 
Group,1=Repiva,2=Repiva+Dexmedet Sl.No Age Weight TSA Ba PR Ba SBP Ba SBP Sen blo Mot Sen time Sen lev Mot TimeMot lev PR 3 Mits
1 1 36 48 I 100 120 80 T8 3 9 T8 12 2 100
1 2 56 46 I 100 120 80 T8 3 9 T8 3 2 100
1 3 50 50 I 70 100 60 T8 3 6 T8 12 2 68
1 4 50 58 I 94 130 80 T8 3 9 T7 3 2 90
1 5 50 55 I 80 130 80 T8 3 3 T8 12 2 90
1 6 38 48 I 100 120 80 T7 3 9 T8 12 2 96
1 7 52 56 I 108 120 80 T8 3 9 T8 9 2 108
1 8 48 50 II 70 100 80 T8 3 6 T8 9 2 68
1 9 38 55 I 108 120 80 T8 3 9 T7 12 2 90
1 10 56 46 II 106 120 80 T8 3 9 T8 12 2 90
1 11 50 56 I 100 130 80 T8 3 9 T8 6 2 96
1 12 52 60 II 78 130 80 T8 3 6 T8 6 2 72
1 13 40 44 I 100 130 80 T7 3 9 T8 9 2 110
1 14 48 50 I 72 120 80 T8 3 6 T8 6 2 70
1 15 36 50 I 90 120 80 T8 3 9 T8 9 2 110
1 16 40 45 I 90 120 80 T7 3 6 T7 12 2 90
1 17 32 60 I 90 130 80 T8 3 9 T8 12 2 90
1 18 32 60 I 96 120 80 T8 3 9 T8 12 2 90
1 19 55 48 I 90 120 80 T8 3 6 T8 6 2 92
1 20 38 48 II 110 128 80 T8 3 9 T8 9 2 110
1 21 58 45 I 96 120 80 T7 3 9 T7 9 2 78
1 22 50 60 I 96 120 80 T8 3 9 T7 9 2 78
1 23 52 56 I 110 130 80 T8 3 3 T8 12 2 108
1 24 36 55 I 90 120 80 T8 3 9 T8 12 2 100
1 25 34 52 I 80 110 70 T8 3 9 T8 9 2 90
1 26 48 48 I 80 110 70 T8 3 9 T8 6 2 68
1 27 32 50 I 90 120 80 T8 3 9 T7 12 2 110
1 28 42 45 I 108 130 80 T7 3 9 T8 6 2 108
1 29 58 45 I 100 130 80 T7 3 9 T8 9 2 92
MASTER CHART
2 1 45 50 I 80 120 80 T7 3 3 T7 6 2 76
2 2 44 54 I 80 120 80 T8 3 3 T8 3 2 108
2 3 46 48 I 80 120 80 T7 3 3 T8 6 2 76
2 4 48 44 I 80 120 80 T8 3 3 T8 3 2 108
2 5 38 45 I 80 120 80 T8 3 3 T7 3 2 108
2 6 54 50 I 82 130 80 T7 3 3 T8 6 2 76
2 7 39 44 I 80 112 80 T7 3 6 T7 6 2 76
2 8 44 45 I 80 112 80 T8 3 6 T8 3 2 108
2 9 40 52 II 76 116 80 T7 3 6 T8 6 2 76
2 10 40 48 I 76 116 80 T7 3 6 T7 6 2 76
2 11 47 49 I 80 120 80 T8 3 6 T8 3 2 108
2 12 48 48 I 80 120 80 T7 3 6 T8 6 2 76
2 13 52 48 I 92 130 80 T8 3 9 T8 3 2 92
2 14 45 45 II 80 120 80 T8 3 3 T8 6 2 108
2 15 48 60 I 80 120 80 T8 3 3 T7 3 2 108
2 16 50 50 I 80 120 80 T8 3 3 T8 3 2 108
2 17 44 52 I 76 116 80 T7 3 9 T8 6 2 76
2 18 47 48 I 80 120 80 T8 3 9 T8 3 2 108
2 19 38 52 I 92 130 80 T8 3 6 T7 6 2 92
2 20 38 48 I 76 116 80 T7 3 6 T7 3 2 76
2 21 50 50 I 76 110 80 T7 3 6 T8 3 2 76
2 22 33 48 I 76 110 70 T8 3 9 T8 6 2 108
2 23 45 50 I 92 120 70 T8 3 3 T8 3 2 92
2 24 50 60 I 92 130 80 T8 3 3 T7 3 2 92
2 25 47 48 I 100 120 80 T8 3 3 T8 6 2 92
2 26 42 45 I 98 120 80 T8 3 9 T7 3 2 92
2 27 50 52 II 106 120 80 T8 3 6 T8 12 2 92
2 28 50 54 I 108 130 80 T8 3 6 T8 12 2 92
2 29 44 52 I 92 130 80 T8 3 6 T7 12 2 92
PR 6 Mits PR 15 Mits PR 30Mits PR 1HR PR 2HR PR 4HR PR 8HR SBP3 Mts SBP6 Mts SBP15 Mts SBP30 Mts SBP 1 Hr SBP 2 Hr SBP 4 Hr
96 92 96 92 90 120 110 120 120 110 120 116 112 128
96 92 96 92 90 120 110 120 120 110 120 116 112 128
66 60 80 86 80 118 108 100 106 80 90 110 120 130
80 64 80 82 82 116 110 120 120 110 112 110 112 136
96 80 78 78 98 126 116 120 110 110 118 120 118 126
86 68 76 76 80 116 114 130 126 112 120 122 118 136
108 104 102 104 110 112 108 130 130 110 110 108 108 126
66 60 60 70 86 118 100 100 106 120 108 110 110 130
96 80 78 78 98 126 116 120 110 108 120 120 118 126
96 84 88 80 80 126 110 120 110 90 92 100 110 130
86 64 68 76 100 116 108 126 126 120 108 112 114 130
78 86 90 90 92 100 108 112 112 108 110 112 106 126
106 100 98 84 90 126 116 130 126 126 120 118 110 126
68 64 68 68 66 86 86 110 108 106 104 102 108 120
106 102 96 90 84 110 100 128 130 126 118 118 116 120
94 64 68 70 74 100 106 120 120 110 110 108 116 130
90 80 68 90 100 110 100 130 130 120 100 110 110 120
88 82 86 86 96 116 116 130 130 110 100 102 100 130
80 66 70 72 72 100 104 120 120 110 110 110 110 140
106 100 102 96 94 108 102 128 130 132 110 110 110 120
74 68 64 68 70 116 108 112 112 108 110 112 116 130
74 68 68 68 70 114 108 114 112 108 110 112 116 130
100 98 96 86 84 112 100 130 130 116 80 106 106 126
102 82 76 82 88 112 106 130 120 110 110 112 114 130
86 80 80 82 84 118 120 130 116 110 110 110 114 128
66 60 64 80 90 122 114 100 102 110 114 120 126 126
106 98 96 86 84 112 100 130 126 124 118 110 112 130
108 90 86 86 80 110 96 130 120 120 110 114 120 136
86 80 74 80 90 108 108 130 120 110 100 96 100 126
70 60 64 70 74 82 110 116 116 110 106 110 118 110
100 98 96 86 90 100 126 118 110 110 106 108 108 114
70 60 64 70 74 82 114 116 116 110 100 108 118 110
100 98 96 86 90 100 126 118 110 110 106 108 108 114
100 98 96 86 90 100 126 118 110 110 106 108 108 114
70 60 64 70 74 82 112 116 116 110 104 100 118 110
70 60 64 70 74 82 110 110 116 110 100 110 118 110
100 98 96 86 90 100 126 108 110 110 106 108 108 114
70 60 64 70 74 82 112 116 116 110 106 110 118 116
70 60 64 70 74 82 112 116 116 110 106 110 118 110
100 98 96 86 90 100 120 118 110 110 106 108 108 114
70 60 55 70 74 82 112 116 116 110 106 110 118 110
80 66 70 88 88 88 96 130 120 106 110 112 116 120
100 98 96 86 90 100 126 118 110 110 106 108 108 114
100 98 96 86 90 100 126 118 110 110 106 108 108 114
100 98 96 86 90 100 126 118 110 110 106 108 108 114
70 60 64 70 74 82 112 116 116 110 108 110 118 110
100 98 96 86 90 100 126 118 110 110 106 108 108 114
80 66 70 88 88 88 100 130 120 106 110 112 116 120
70 60 64 70 74 82 112 116 116 110 106 110 118 110
70 60 54 70 74 82 112 116 116 110 104 110 118 110
100 98 96 86 90 100 126 118 110 110 106 108 108 114
80 66 70 88 88 88 100 130 120 106 110 112 116 120
80 66 70 88 88 88 100 130 120 106 110 112 116 120
80 66 70 88 88 88 100 130 120 106 110 112 116 120
80 66 70 88 88 88 100 130 120 106 110 112 116 120
80 66 70 88 88 88 100 130 120 106 110 112 116 120
80 66 70 88 88 80 90 130 120 106 110 112 116 120
80 66 70 88 88 88 100 130 120 106 110 112 116 120
SBP 8 Hr DBP3 Mts DBP6 Mts DBP15 Mts DBP30 Mts DBP 1 Hr DBP 2 Hr DBP 4 Hr DBP 8 Hr  Analg Dura Mts VAS lev 2 seg reg Mts S2 Reg Mts
126 80 80 70 80 70 70 80 82 240 4 80 240
126 80 80 70 80 70 70 80 82 240 5 80 240
110 60 60 60 60 70 80 90 70 200 6 60 220
120 80 80 70 70 70 70 90 80 240 4 80 240
118 80 70 70 70 70 70 70 60 200 5 80 270
120 80 80 70 70 70 68 90 80 240 6 80 220
106 80 80 70 70 70 70 70 70 220 4 120 240
110 60 60 60 70 70 70 90 74 200 5 80 270
118 80 70 70 80 70 70 70 60 200 6 80 220
110 80 80 60 60 60 70 80 70 200 4 80 240
118 80 80 80 70 70 76 80 70 240 4 80 270
120 80 70 60 70 70 70 70 70 200 4 100 220
120 80 80 80 80 80 70 80 70 220 4 120 240
110 70 70 60 68 62 70 80 70 200 5 80 270
118 80 80 80 80 70 70 70 70 220 6 120 220
120 80 80 80 70 70 70 80 70 240 4 80 240
130 80 80 70 70 70 70 80 80 200 4 80 270
120 80 80 70 70 70 60 80 80 200 4 80 220
122 80 80 80 80 80 80 90 80 240 4 80 240
120 80 80 80 80 70 70 70 70 220 5 120 270
112 70 70 60 66 70 70 72 70 200 6 100 220
112 70 70 60 64 70 70 72 70 200 4 100 240
116 80 80 80 60 70 70 70 70 220 4 120 270
116 90 80 70 70 70 72 80 80 240 4 80 220
108 80 70 70 60 60 66 70 80 200 4 80 240
120 60 60 60 70 80 80 70 70 220 5 60 270
120 80 80 80 80 70 70 80 70 220 6 120 220
118 80 80 70 70 70 70 90 80 240 5 80 240
120 80 80 70 70 60 60 80 70 200 6 80 270
150 80 80 70 60 70 70 70 80 450 4 120 300
126 70 70 70 70 70 70 70 80 430 5 140 270
130 80 80 70 60 60 70 70 80 450 4 120 270
126 70 70 70 70 70 70 70 80 430 6 140 240
126 70 70 70 70 70 70 70 80 430 4 140 270
130 80 80 70 60 70 70 70 80 450 4 120 330
130 80 80 70 60 70 70 70 90 450 4 120 300
126 70 70 70 70 70 70 70 80 430 4 100 330
130 80 80 70 60 70 70 70 80 450 5 120 300
130 80 80 70 60 70 70 70 80 450 4 120 330
120 70 70 70 70 70 70 70 80 430 4 140 300
130 80 80 70 60 70 70 70 80 450 6 120 330
130 80 80 70 70 70 80 80 90 480 4 140 330
120 70 70 70 70 70 70 70 80 430 4 140 300
126 70 70 70 70 70 70 70 80 430 4 140 330
126 70 70 70 70 70 70 70 80 430 8 140 270
130 80 80 70 60 70 70 70 80 450 4 120 300
126 70 70 70 70 70 70 70 80 430 4 140 330
130 80 80 70 70 70 80 80 90 480 4 140 300
130 80 80 70 60 70 70 70 80 450 5 120 330
130 80 80 70 60 70 70 70 80 450 4 120 300
126 70 70 70 70 70 70 70 80 450 4 140 270
130 80 80 70 70 70 80 80 90 480 6 140 300
130 90 80 70 70 70 80 80 90 480 4 140 270
130 80 80 70 70 70 80 80 90 480 4 140 300
130 80 80 70 70 70 80 80 90 480 7 140 270
130 80 80 70 70 70 80 80 90 480 4 140 300
130 80 80 70 70 70 80 80 90 480 4 140 270
130 80 80 70 70 70 80 80 90 480 7 140 300
Group I 3 Mts 6 Mts 15 Mts 30 Mts 1 Hr 1.30 Hrs 2 Hrs 2.30 Hrs 3 Hrs 3.30 Hrs 4 Hrs 4.30 Hrs 5 Hrs
1 2 2 3 3 3 2 2 0 0 0 0 0 0
2 2 2 2 3 3 3 2 2 1 0 0 0 0
3 2 2 3 3 3 2 2 1 0 0 0 0 0
4 2 3 3 3 3 3 2 1 1 0 0 0 0
5 1 1 2 3 2 1 1 1 0 0 0 0 0
6 2 2 2 3 3 3 2 0 0 0 0 0 0
7 0 1 2 2 3 3 2 1 1 0 0 0 0
8 0 2 2 3 3 2 1 1 0 0 0 0 0
9 0 1 2 2 3 3 2 0 0 0 0 0 0
10 0 2 3 3 3 2 2 0 0 0 0 0 0
11 0 2 3 3 2 2 1 1 0 0 0 0 0
12 0 1 2 2 2 2 1 1 1 0 0 0 0
13 0 2 2 3 2 2 1 1 0 0 0 0 0
14 0 1 2 2 3 2 2 0 0 0 0 0 0
15 0 1 2 2 3 2 2 0 0 0 0 0 0
16 0 1 2 2 3 2 2 1 0 0 0 0 0
17 0 1 2 2 3 3 2 2 1 0 0 0 0
18 0 0 2 2 3 2 2 0 0 0 0 0 0
19 0 2 3 3 3 2 2 1 0 0 0 0 0
20 1 2 2 3 3 2 2 1 1 0 0 0 0
21 0 1 2 3 2 2 2 1 0 0 0 0 0
22 0 0 2 3 3 2 2 0 0 0 0 0 0
23 0 0 2 2 3 3 2 1 0 0 0 0 0
24 1 2 2 3 3 2 2 1 1 0 0 0 0
25 0 0 2 3 2 2 2 2 0 0 0 0 0
26 1 2 2 3 3 3 3 2 0 0 0 0 0
27 0 0 2 3 3 3 2 0 0 0 0 0 0
28 0 2 2 3 3 3 2 1 0 0 0 0 0
29 0 1 2 2 3 3 3 2 2 0 0 0 0
MOTOR BLOCKADE - DURATION
Group II
1 1 2 2 3 3 3 3 3 2 1 0 0 0
2 2 2 2 2 2 2 2 2 2 1 0 0 0
3 1 2 2 3 3 2 2 2 2 1 1 0 0
4 1 2 2 2 3 3 3 2 1 1 0 0 0
5 2 2 3 3 3 3 2 2 1 1 1 0 0
6 1 2 3 3 3 2 2 2 1 1 0 0 0
7 0 1 2 3 3 3 3 2 1 1 1 0 0
8 2 2 3 3 3 3 3 3 2 2 0 0 0
9 1 2 2 2 2 3 3 2 2 1 1 0 0
10 2 2 3 3 3 2 2 1 1 1 0 0 0
11 2 2 3 3 3 3 2 2 1 1 1 0 0
12 2 2 3 3 3 3 2 2 2 1 1 0 0
13 1 2 2 2 3 3 3 2 2 1 1 0 0
14 0 2 2 2 2 3 3 2 2 2 0 0 0
15 0 1 2 2 3 3 3 2 1 1 1 0 0
16 2 2 2 2 3 3 2 2 2 2 2 0 0
17 2 3 3 3 3 3 3 3 3 3 0 0 0
18 1 2 2 2 2 3 3 2 2 1 1 0 0
19 1 2 2 2 3 3 2 2 1 1 0 0 0
20 2 2 3 3 2 2 2 1 1 1 1 0 0
21 0 2 3 3 2 2 2 2 1 1 0 0 0
22 2 2 2 2 2 3 3 2 2 1 1 0 0
23 1 2 2 2 3 3 3 2 2 1 0 0 0
24 2 2 2 3 3 2 2 2 2 1 1 0 0
25 1 2 2 2 2 3 3 2 2 2 1 0 0
26 2 3 3 3 2 2 2 2 2 2 0 0 0
27 2 2 2 2 2 2 3 3 2 2 1 1 0
28 0 1 2 2 3 3 2 2 2 2 1 1 0
29 2 2 2 2 3 3 3 2 1 0 0 0 0
 
